US20160151177A1 - Stent with Outer Member to Embolize an Aneurysm - Google Patents

Stent with Outer Member to Embolize an Aneurysm Download PDF

Info

Publication number
US20160151177A1
US20160151177A1 US14/562,725 US201414562725A US2016151177A1 US 20160151177 A1 US20160151177 A1 US 20160151177A1 US 201414562725 A US201414562725 A US 201414562725A US 2016151177 A1 US2016151177 A1 US 2016151177A1
Authority
US
United States
Prior art keywords
aneurysm
stent
inner structure
flexible layer
outer flexible
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
US14/562,725
Other versions
US9358140B1 (en
Inventor
Robert A. Connor
Muhammad Tariq Janjua
Mark Knudson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aneuclose LLC
Original Assignee
Robert A. Connor
Muhammad Tariq Janjua
Mark Knudson
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US12/592,116 external-priority patent/US20100131002A1/en
Application filed by Robert A. Connor, Muhammad Tariq Janjua, Mark Knudson filed Critical Robert A. Connor
Priority to US14/562,725 priority Critical patent/US9358140B1/en
Publication of US20160151177A1 publication Critical patent/US20160151177A1/en
Application granted granted Critical
Publication of US9358140B1 publication Critical patent/US9358140B1/en
Assigned to ANEUCLOSE LLC reassignment ANEUCLOSE LLC ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: CONNOR, ROBERT A.
Assigned to ANEUCLOSE LLC reassignment ANEUCLOSE LLC ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: JANJUA, MUHAMMAD TARIQ
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022Occluding by internal devices, e.g. balloons or releasable wires
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022Occluding by internal devices, e.g. balloons or releasable wires
    • A61B17/12099Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder
    • A61B17/12109Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder in a blood vessel
    • A61B17/12113Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder in a blood vessel within an aneurysm
    • A61B17/12118Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder in a blood vessel within an aneurysm for positioning in conjunction with a stent
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022Occluding by internal devices, e.g. balloons or releasable wires
    • A61B17/12131Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
    • A61B17/12181Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device formed by fluidized, gelatinous or cellular remodelable materials, e.g. embolic liquids, foams or extracellular matrices
    • A61B17/1219Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device formed by fluidized, gelatinous or cellular remodelable materials, e.g. embolic liquids, foams or extracellular matrices expandable in contact with liquids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • A61F2/91Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/02Inorganic materials
    • A61L31/022Metals or alloys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/08Materials for coatings
    • A61L31/10Macromolecular materials
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/18Materials at least partially X-ray or laser opaque
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B2017/00831Material properties
    • A61B2017/00898Material properties expandable upon contact with fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B90/00Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
    • A61B90/39Markers, e.g. radio-opaque or breast lesions markers
    • A61B2090/3925Markers, e.g. radio-opaque or breast lesions markers ultrasonic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/04Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
    • A61F2/06Blood vessels
    • A61F2/07Stent-grafts
    • A61F2002/075Stent-grafts the stent being loosely attached to the graft material, e.g. by stitching
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2002/823Stents, different from stent-grafts, adapted to cover an aneurysm
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2250/00Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2250/0058Additional features; Implant or prostheses properties not otherwise provided for
    • A61F2250/0065Additional features; Implant or prostheses properties not otherwise provided for telescopic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00Materials or treatment for tissue regeneration
    • A61L2430/36Materials or treatment for tissue regeneration for embolization or occlusion, e.g. vaso-occlusive compositions or devices

Definitions

  • This invention relates to devices to treat aneurysms.
  • An aneurysm is an abnormal bulging or ballooning of a blood vessel. Rupture of brain aneurysms can cause stroke, death, or disability. Around one-third of people who have a brain aneurysm that ruptures will die within 30 days of the rupture. Of the survivors, around half of them suffer some permanent loss of brain function. Many aneurysms are not identified until they rupture. However, identification of intact aneurysms is increasing due to increased outpatient imaging. Ruptured aneurysms must be treated to stop the bleeding or to prevent re-bleeding. Intact aneurysms may or may not be treated to prevent rupture, depending on their characteristics. Wide neck aneurysms are less prone to rupture, but are harder to treat. In the U.S., it has been estimated that over 10 million people have brain aneurysms and 30,000 people each year have a brain aneurysm that ruptures.
  • Clipping is the application of a small clip to the aneurysm neck from outside the vessel to seal off the aneurysm. For most brain aneurysms, this involves invasive surgery including removing a section of the skull. Clipping began in the 1930's and is well-established. Clipping is more common in the U.S. than in Europe. Around half of all aneurysms are treated by clipping. There are many aneurysm clips in the prior art. However, due to its invasive nature, clipping is decreasing. Potential disadvantages of clipping can include: significant health risks associated with major surgery of this type; and long recovery times, even when the surgery itself goes well.
  • Metal coiling is the endovascular insertion of metal coils into the aneurysm to reduce blood flow and promote embolization in the aneurysm. Historically, metal coils have been platinum. Coils are more common in Europe than in the U.S. There are many examples of metal coils.
  • metal coils can include: low percentage of aneurysm volume filled (low occlusion is associated with a higher risk of rupture); compaction of coils over time; risk of recanalization; potential prolapse of coils into the parent vessel; difficulty later clipping aneurysms filled with metal coils, if needed; pressure from the coils on surrounding brain tissue; inability of coils to treat all aneurysms; and expense of metal coils (especially platinum coils).
  • Combination Metal/Textile/Foam/Gel Coils Coils with a combination of metal and other materials can be used to try to achieve greater occlusion volume than metal coils alone. These other materials include textile, foam, and gel elements. Textile strands can be woven into the coils to add bulk. Coils can be covered with soft foam. Gel elements can be strung together into elongated structures. Examples of related art that appear to use this approach includes the following: U.S. Pat. Nos.
  • Patent Applications 20040158282 Jones, Donald et al.), 20050267510 (Razack, Nasser), and 20060058834 (Do, Hiep et al.).
  • Potential disadvantages of combination coils can include: remaining gaps between loops; compaction of coils over time; risk of recanalization; potential prolapse of coils into the parent vessel; difficulty clipping aneurysms filled with coils with metal components later if needed; pressure from the coils on surrounding brain tissue; inability of coils to treat all aneurysms; and expense of metal coils.
  • Inflatable Balloons Approximately two decades ago, there were numerous efforts to treat aneurysms by permanently filling them with inflatable balloons. These efforts were largely abandoned due to the risks of balloon deflation, prolapse into the parent vessel, aneurysm rupture, and recanalization. There are, however, examples of relatively recent art that appear to use inflatable balloons to treat aneurysms: U.S. Pat. Nos. 6,569,190 (Whalen et al.) and 7,083,643 (Whalen et al.), and U.S.
  • Patent Applications 20030135264 (Whalen et al.), 20030187473 (Berenstein, Alejandro et al.), 20060292206 (Kim, Steven et al.), 20070050008 (Kim, Steven et al.), and 20070055355 (Kim, Steven et al.).
  • Potential disadvantages of using inflatable balloons to permanently fill aneurysms can include: balloon deflation; prolapse of the balloon into the parent vessel; aneurysm rupture due to balloon pressure; and recanalization.
  • a mesh structure generally metal, that can be expanded or contracted by human-controlled mechanical motion so as to block the aneurysm neck and/or to fill the main volume of the aneurysm.
  • a wire structure can be inserted through the aneurysm neck in a narrow configuration and then transformed into an “hour-glass” shape that collapses to block the aneurysm neck when activated by a human controller. Examples of related art that appear to use this approach include the following: U.S. Pat. Nos.
  • Patent Applications 20020042628 Choin, Yem et al.), 20020169473 (Sepetka, Ivan et al.), 20030083676 (Wallace, Michael), 20030181927 (Wallace, Michael), 20040181253 (Sepetka, Ivan et al.), 20050021077 (Chin et al.), 20060155323 (Porter, Stephen et al.), 20070088387 (Eskridge, Joseph et al.), 20070106311 (Wallace, Michael et al.), and 20080147100 (Wallace, Michael).
  • Self-Expanding Standard-Shape Occluders Another approach to treating aneurysms uses standard-shaped structures that self-expand when released into the aneurysm.
  • the structure may be a mesh of “shape memory” metal that automatically expands to a standard shape when released from the confines of the catheter walls.
  • the structure may be a gel that expands to a standard shape when exposed to moisture. Examples of related art that appear to use this approach include the following: U.S. Pat. Nos.
  • Patent Applications 20030093097 (Avellanet, Ernesto et al.), 20030195553 (Wallace, Michael et al.), 20050033349 (Jones, Donald et al.), 20060052816 (Bates, Brian et al.), and 20060235464 (Avellanet, Ernesto et al.) and WIPO Patents WO/2006/084077 (Porter, Stephen et al.) and WO/1996/018343 (McGurk et. al.).
  • Such self-expanding standard-shape structures can include: risk of prolapse into the parent vessel, especially for wide-neck aneurysms; difficulty occluding irregularly-shaped aneurysms with standard shape structures and associated risk of recanalization; and difficulty generating the proper amount of force (not too much or too little) when engaging the aneurysm walls with a standard-shaped self-expanding structure.
  • Self-Expanding Custom-Modeled Occluders A variation on self-expanding standard-shape occluders (discussed above) are self-expanding occluders that are custom modeled before insertion so as to fit the shape of a particular aneurysm. As an example sequence—the aneurysm can be imaged, the image is used to custom model the occluding structure, the occluding structure is compressed into a catheter, the occluding structure is inserted into the aneurysm, and the occluding structure then self-expands to fill the aneurysm.
  • the occluding structure may be made from a gel that expands upon contact with moisture.
  • Potential disadvantages of self-expanding custom-modeled occluders can include: the complexity and expense of imaging and modeling irregularly-shaped aneurysms; difficulty compressing larger-size structures into a catheter; difficulty inserting the occluding structure in precisely the correct position; and difficulty getting a gelatinous surface to anchor solidly to aneurysm walls.
  • Congealing Liquid or Gel Another approach to treating aneurysms involves filling an aneurysm with a liquid or gel that congeals rapidly. Examples of related art that appear to use this approach include the following: U.S. Pat. Nos. 6,569,190 (Whalen et al.), 6,626,928 (Raymond et al.), 6,958,061 (Truckai et al.), and 7,083,643 (Whalen et al.), and U.S. Patent Application 20030135264 (Whalen et al.).
  • a congealing liquid or gel can include: leakage of the congealing substance into the parent vessel, potentially causing a stroke; difficulty filling the entire aneurysm if the substance begins to congeal before the aneurysm is full; and seepage of toxic substances into the blood stream.
  • Biological and/or pharmaceutical agents can enhance the performance of a variety of mechanical treatment methods for aneurysms. For example, they can speed up the natural embolization process to occlude the aneurysm. Examples of related art that appear to use this approach include the following: U.S. Patent Applications 20060206139 (Tekulve, Kurt J.), 20070168011 (LaDuca, Robert et al.), and 20080033341 (Grad, Ygael).
  • U.S. Patent Applications 20060206139 Tekulve, Kurt J.
  • 20070168011 LaDuca, Robert et al.
  • 20080033341 Grad, Ygael
  • biological and/or pharmaceutical approaches are not sufficient as stand alone treatment approaches for many cases. Accordingly, they share most of the potential disadvantages of the baseline approach to which the biological or pharmaceutical agents are added.
  • Embolic-Emitting Expanding Members Another approach involves an expanding member within the aneurysm that emits embolic elements into the aneurysm.
  • expanding members include bags, meshes, and nets.
  • embolic elements include coils and congealing liquids. This can be viewed as another way to block the aneurysm neck while delivering embolics into the volume of the aneurysm.
  • the distal portion of an expanding bag may leak embolic elements into the aneurysm, but the proximal portion of the expanding member does not leak embolics into the parent vessel. Examples of related art that appear to use this approach include the following: U.S. Pat. No.
  • Shape Memory Structures inside Expanding Members A variation on the shape memory approach above involves the addition of an expanding member around the shape memory structure. Examples of related art that appear to use this approach include the following: U.S. Pat. Nos. 5,861,003 (Latson et al.), 6,346,117 (Greenhalgh), 6,350,270 (Roue), 6,391,037 (Greenhalgh), and 6,855,153 (Saadat).
  • Standard (High-Porosity) Stent A stent is a structure that is inserted into a vessel in a collapsed form and then expanded into contact with the vessel walls. Standard stents are generally highly porous, metal, and cylindrical. A high-porosity stent allows blood to flow through the stent walls if there are any branching or secondary vessels in the vessel walls. Blood flow through a stent wall into a branching or secondary vessel is desirable, but blood flow through a stent wall into an aneurysm is not. Accordingly, a high-porosity stent in the parent vessel is not a good stand-alone aneurysm treatment. A high-porosity stent in the parent vessel can, however, help to keep coils or other embolic members from escaping out of the aneurysm into the parent vessel.
  • a high-porosity stent in the parent vessel in combination with coils in the aneurysm still leaves the following disadvantages of using coils alone: low percentage of aneurysm volume filled (and low occlusion is associated with a higher risk of rupture); compaction of coils over time; significant risk of recanalization; difficulty clipping aneurysms filled with metal coils later if needed; pressure from the coils on surrounding brain tissue; inability of coils to treat all aneurysms; and expense of metal coils (especially platinum coils).
  • Uniformly Low-Porosity Stent Another approach involves inserting a uniformly low-porosity stent into the parent vessel.
  • the low-porosity stent blocks the flow of blood through the stent walls into the aneurysm, causing beneficial embolization of the aneurysm.
  • the stent may have one or more layers that are impermeable to the flow of liquid.
  • this approach can be used as a stand-alone aneurysm treatment. Examples of related art that appear to use this approach include the following: U.S. Pat. Nos.
  • Patent Application 20080319521 (Norris et al., 2008). Potential disadvantages of this approach can include: undesirably blocking blood flow to branching or secondary vessels that are close to the aneurysm and are covered by the stent wall; difficulty achieving a snug fit across the neck of the aneurysm if the parent vessel is curved, twisted, or forked; and poor attachment of the stent with the parent vessel wall due to the impermeable nature of the stent wall.
  • Uniformly Intermediate-Porosity Metal Stent This approach pursues creation of a stent with a uniform intermediate porosity that provides a compromise between the benefits of a high-porosity stent in the parent vessel (good blood flow to nearby branching or secondary vessels) and the benefits of a low-porosity stents in the parent vessel (blocking blood flow to the aneurysm).
  • Examples of related art that appear to use this approach include the following: U.S. Pat. Nos. 6,770,087 (Layne et al., 2004), 7,052,513 (Thompson, 2006), and 7,306,624 (Yodfat et al., 2007), and U.S.
  • Patent Applications 20070207186 (Scanlon et al.,2007), 20070219619 (Dieck et al., 2007), 20070276470 (Tenne, 2007), 20070276469 (Tenne, 2007), and 20080039933 (Yodfat et al., 2008).
  • the main potential disadvantage of this approach is that it may perform neither function very well. It may unreasonably block flow to a branching or secondary vessels (causing a stroke) and may inadequately block blood flow to the aneurysm (leaving it vulnerable to rupture).
  • Pre-Formed Differential Porosity Stent This approach involves creating a stent with different levels of porosity for different wall areas, before the stent is inserted into the parent vessel. The goal is two-fold: (1) to place wall areas with high porosity over openings to branching or secondary vessels; and (2) to place wall areas with low porosity over the neck of the aneurysm. Examples of related art that appear to use this approach include the following: U.S. Pat. Nos.
  • Potential disadvantages of this approach include: difficulty injecting the embolizing substance through the stent wall without having it leak back into the parent vessel; leakage of embolizing liquid or gel between the stent and the parent vessel into the blood stream, where it blocks a downstream vessel and causes a stroke; challenges containing the embolic material within curving vessels or vessels with irregular walls; and difficulty using this method to fill narrow-neck aneurysms.
  • Post-Implantation Surface Modification This approach creates different degrees of porosity in different wall areas after the stent is implanted. The goal is to decrease the porosity of the stent wall in the area of the aneurysm neck, but to leave the rest of the stent wall relatively porous to allow blood flow to branching or secondary members. Also, high porosity in other areas of the stent wall aids in the attachment and integration of the stent to the parent vessel.
  • this approach does not fill the gap between the stent wall and the parent vessel wall with some type of solidifying liquid, but rather modifies the wall of the stent itself This reduces the risk of embolic liquid or members leaking out between the stent and the parent vessel wall into the blood stream.
  • This invention can be embodied in a stent system that is inserted into the parent vessel of an aneurysm in order to reduce blood flow to the aneurysm and promote embolization of the aneurysm.
  • the stent wall includes an inner structure, such as an expandable metal mesh, that can be expanded from a compressed state to a resilient expanded state and an outer flexible layer, such as a flexible fabric net, that covers all or part of the inner structure.
  • Embolic members are placed and retained in the gap between the inner structure and the outer layer in the area of the aneurysm neck in order to reduce blood flow to the aneurysm.
  • This invention can also be embodied in a stent to reduce blood flow to an aneurysm comprising: (a) an inner member, wherein this inner member is expanded from a first configuration to a second configuration within the parent vessel of an aneurysm, wherein the circumference of the second configuration is larger than the circumference of the first configuration; and (b) an outer member, wherein this outer member is less porous than the inner member, wherein this outer member covers or surrounds a first percentage of the surface area of the inner member when the inner structure is in the first configuration, wherein this outer member covers or surrounds a second percentage of the surface area of the inner member when the inner structure is in the second configuration, and wherein the second percentage less than the first percentage.
  • FIGS. 1 through 24 show possible embodiments of this stent, but do not limit the full generalizability of the claims.
  • FIG. 1 shows an opaque side view of one embodiment of this stent after it has been inserted and expanded within the parent blood vessel of an aneurysm.
  • FIG. 2 shows an alternative view of this same embodiment, with the two layers of the stent being transparent in order to allow a clearer view of the guidewires.
  • FIG. 3 shows an opaque side view of this same embodiment, except that a catheter to deliver embolic members has now been slid along the guidewires to reach an opening in the inner mesh structure.
  • FIG. 4 shows an alternative view of this same embodiment with the two layers of the stent being transparent in order to allow a clearer view of the catheter and the embolic members.
  • FIG. 5 shows an opaque side view of this same embodiment, except that a plurality of embolic members have now been inserted into the gap between the inner mesh structure and the outer flexible layer in the area of the aneurysm neck.
  • FIG. 6 shows an alternative view of this same embodiment with the two layers of the stent being transparent in order to allow a clearer view of the catheter and the embolic members.
  • FIGS. 7 and 8 show this same embodiment after the detachment and withdrawal of the guidewires and catheter.
  • FIG. 9 shows a close-up view of guidewires attached to the inside surface of a hexagonal opening in the inner mesh structure.
  • FIG. 10 shows a close-up view of the distal end of the catheter as it slides along the guidewires toward the inner mesh structure.
  • FIG. 11 shows a close-up view of the distal end of the catheter after it has completely slid along the guidewires to reach the inner mesh structure and be aligned with an opening in this inner mesh structure.
  • FIG. 12 shows a close-up view of embolic members being propelled through the catheter by a flow of sterile saline solution.
  • FIG. 13 shows a close-up view of a plurality of embolic members having been inserted into the gap between the inner mesh structure and the outer flexible layer, with both guidewires and catheter having been withdrawn.
  • FIGS. 14 and 15 show examples of this stent with a high-flexibility area of the outer flexible layer that is identified by radioopaque lines and that is positioned to cover the aneurysm neck.
  • FIGS. 16 through 18 show an example of a stent with a sliding outer flexible layer that is connected to an inner structure along arcuate ribs.
  • FIGS. 19 through 21 show an example of a stent with a sliding outer flexible layer that is held onto an inner structure by arcuate ribs.
  • FIGS. 22 through 24 show an example of a stent with a sliding outer flexible layer that is connected to an inner structure by partially-detachable connections.
  • FIGS. 1 through 24 show possible embodiments of this stent. However, these embodiments are not exhaustive. These figures do not limit the full generalizability of the claims.
  • FIG. 1 shows an opaque side view of one embodiment of this stent, after it has been inserted and expanded within the parent blood vessel of an aneurysm.
  • FIG. 1 also shows a cross-sectional side view of the parent blood vessel 103 with aneurysm 101 including aneurysm neck 102 .
  • the stent system has a resilient inner structure 104 , which is a metal mesh with a hexagonal pattern, and an outer flexible layer 105 that is configured like a net around the inner structure.
  • FIG. 1 also shows two guidewires 106 that are attached to inner structure 104 .
  • the stent is shown in FIG. 1 in an already inserted and expanded configuration. Many methods of stent insertion and expansion, such as by catheter and balloon, are well known in the art and the precise methods of insertion and expansion are not central to this invention.
  • the wall of the stent consists of two layers.
  • the inner layer of the stent wall is an expandable and resilient metal mesh structure 104 with a hexagonal pattern. Many other types of expandable mesh structures may also be used.
  • this inner mesh structure may be made from stainless steel, a nickel-titanium alloy, cobalt chromium or a cobalt-chromium alloy, titanium or a titanium alloy, tantalum or a tantalum allow, or polymeric-based resin or another polymer.
  • the outer layer of the stent is a flexible fabric net 105 .
  • the outer flexible layer may be made from latex, nylon, polyester, teflon, silicone, HDPE, polycarbonate urethane, polyether-polyamide copolymer, polyethylene terephthalate, polyolefin, polypropylene, polytetrafluorethylene, polytetrafluoroethene, polyurethane, or polyvinyl chloride.
  • the inner mesh structure and the outer flexible layer there is a gap between the inner mesh structure and the outer flexible layer and these layers are not connected to each other. In other examples of this invention, there may be no gap between these layers until embolic members are inserted between them in the area of the aneurysm neck.
  • the two layers may be connected at multiple points or seams in order to form separate pouches between the layers for more precise localized containment of the embolic members between the layers.
  • the wall may be comprised of more than two layers.
  • FIG. 2 shows an alternative view of the same embodiment of this stent that is shown in FIG. 1 .
  • FIG. 2 is the same as FIG. 1 except that FIG. 2 shows the two layers of the stent as transparent in order to allow a clearer view of two guidewires 106 that are attached to the inner mesh structure of the stent wall.
  • these two guidewires 106 were attached to the inner structure of the stent at a specific point before insertion of the stent and the operator has aligned this point with the aneurysm neck 102 during stent placement within the parent vessel 103 .
  • these two guidewires 106 will be used to guide a catheter that delivers embolic members into the gap between the inner wall structure 104 and the outer flexible layer 105 .
  • guidewires need not be used; the catheter may be directed to the inner wall structure using real-time imaging and attached to the inner wall structure with a grasping or hooking mechanism.
  • FIG. 3 shows an opaque side view of the same embodiment of this stent that is shown in FIG. 1 , except that a catheter 301 to deliver embolic members (including embolic member 302 ) has been slid along guidewires 106 to reach an opening in the inner mesh structure 104 .
  • embolic members including 302
  • sterile embolic members are propelled by a flow of sterile saline solution through catheter 301 for insertion into the gap between inner mesh structure 104 and outer flexible layer 105 .
  • the saline solution propels the embolic members through the catheter and into the gap, wherein the members expand and are trapped within the gap.
  • the saline solution escapes through the openings in the mesh.
  • other means may be used to transport the embolic members along the catheter, such as miniature conveyor belts or rotating helix mechanisms.
  • the embolic members are compressible micro-sponges that expand upon ejection from the catheter.
  • these micro-sponges may be made from cellulose, collagen, acetate, alginic acid, carboxy methyl cellulose, chitin, collagen glycosaminoglycan, divinylbenzene, ethylene glycol, ethylene glycol dimethylmathacrylate, ethylene vinyl acetate, hyaluronic acid, hydrocarbon polymer, hydroxyethylmethacrylate, methlymethacrylate, polyacrylic acid, polyamides, polyesters, polyolefins, polysaccharides, polyurethane, polyvinyl alcohol, silicone, urethane, and vinyl stearate.
  • the embolic members may be gels, beads, or coils.
  • the embolic members (such as 302 ) are retained with the gap between the inner mesh structure 104 and outer flexible layer 105 because they expand upon ejection from the catheter 301 and can not exit the same opening in the inner mesh structure by which they entered this gap.
  • the embolic members need not expand, but the opening by which they enter the gap may be closed when the catheter is removed to trap them within the gap.
  • FIG. 4 shows an alternative view of the same embodiment of this stent that is shown in FIG. 3 , except that the two layers of the stent are transparent in order to allow a clearer view of catheter 301 and embolic members (including 302 ).
  • FIG. 5 shows an opaque side view of the same embodiment of this stent that is shown in FIG. 3 , except that a plurality of embolic members (including 302 ) have now been delivered via catheter 301 and inserted into the gap between the inner mesh structure 104 and the outer flexible layer 105 in the area of the aneurysm neck.
  • the flexibility of outer layer 105 allows it to distend into the aneurysm neck to more thoroughly block blood flow through the neck.
  • a sufficient volume of embolic members has been inserted into this gap in the area of the aneurysm neck to occlude the flow of blood into aneurysm 101 , thereby promoting embolization of the aneurysm.
  • FIG. 6 shows an alternative view of the same embodiment of this stent that is shown in FIG. 5 , except that the two layers of the stent are transparent in order to allow a clearer view of catheter 301 and embolic members (including 302 ).
  • FIGS. 7 and 8 show the same embodiment, but after the detachment and withdrawal of the guidewires 106 and catheter 301 .
  • the guidewires may be detached from the inner mesh structure by application of a mild electric current and the catheter may be removed by simple mechanical withdrawal.
  • Many other methods for detaching and removing guidewires and catheters are known in the prior art and the exact detachment and removal mechanisms are not central to this invention.
  • Blood flow through the aneurysm neck is now largely blocked to promote embolization of the aneurysm, but other areas of the stent remain largely porous to foster integration with the walls of the parent vessel and to allow blood flow to any secondary vessels that may branch off from the parent vessel along the length of the stent.
  • FIGS. 9 through 13 show greater detail for one example of how the guidewires and catheter function to transport embolic members into the gap between the inner mesh structure and the outer flexible layer of the stent wall.
  • FIGS. 9 through 13 show greater detail for one example of how the guidewires and catheter function to transport embolic members into the gap between the inner mesh structure and the outer flexible layer of the stent wall.
  • FIGS. 9 through 13 show greater detail for one example of how the guidewires and catheter function to transport embolic members into the gap between the inner mesh structure and the outer flexible layer of the stent wall.
  • only small square patches of inner mesh structure 104 and outer flexible layer 105 are shown (indicated by dashed line borders); and the size of the gap between these two layers is exaggerated to provide a clearer view of how embolic members are inserted within this gap.
  • guidewires 106 are attached to inner mesh structure 104 before the stent is inserted in the parent vessel and catheter 301 is guided to the inner mesh structure 104 by means of
  • FIG. 9 shows a close-up view of guidewires 106 attached to the inside surface of a hexagonal opening in inner mesh structure 104 .
  • FIG. 9 also shows outer flexible layer 105 .
  • FIG. 9 corresponds to a close-up view of a small area of FIGS. 1 and 2 , the area in which guidewires 106 are attached to inner mesh structure 104 .
  • FIG. 10 shows a close-up view of the distal end 1001 of catheter 301 as it slides along guidewires 106 toward inner mesh structure 104 . The other (proximal) end of catheter 301 remains outside the person's body.
  • FIG. 11 shows a close-up view of the distal end 1001 of catheter 301 after it has completely slid along guidewires 106 to reach inner mesh structure 104 and be aligned with one hexagonal opening of this structure.
  • FIG. 12 shows a close-up view of embolic members (including 302 ) being propelled through catheter 301 by a flow of sterile saline solution.
  • the embolic members are micro-sponges that expand upon ejection from the catheter into the gap between the inner mesh structure 104 and outer flexible layer 105 .
  • FIG. 12 corresponds to a close-up view of a small area of FIGS. 3 and 4 , the area in which the guidewires 106 are attached to the inner mesh structure 104 .
  • FIG. 13 shows a close-up view of a plurality of embolic members having been inserted into the gap between the inner mesh structure 104 and outer flexible layer 105 . Also, guidewires 106 and catheter 301 have been detached and withdrawn. FIG. 13 corresponds to a close-up view of a small area of FIGS. 7 and 8 , the area in which the guidewires were attached to the inner mesh structure.
  • FIGS. 14 and 15 show an opaque side view of two examples of this stent that feature an outer flexible layer with differential flexibility. Having a stent with one area of the outer flexible layer that has greater flexibility and placing this area over the aneurysm neck has two advantages. First, it facilitates insertion of a substantial mass of embolic members into the gap between the inner mesh and the outer flexible layer in the area of the aneurysm neck in order to thoroughly occlude the aneurysm neck. Second, although the walls of the parent vessel resist migration of embolic members through the gap away from the aneurysm neck area, having less flexibility of the outer layer outside the aneurysm neck area provides additional resistance to possible migration of embolic members.
  • FIGS. 14 and 15 show a stent, with an inner structural mesh 104 and an outer flexible net 105 , having been inserted into parent vessel 103 of aneurysm 101 with aneurysm neck 102 .
  • FIGS. 14 and 15 also show a saddle-shaped area 1401 of the outer flexible net that has greater flexibility than the rest of the net. This saddle-shaped area with greater flexibility is positioned to cover the aneurysm neck when the stent is placed and expanded.
  • the stent also features radioopaque lateral and longitudinal lines that help the operator to align the saddle-shaped area with the aneurysm neck during placement and expansion of the stent.
  • the saddle-shaped area 1401 is identified for the operator by radioopaque longitudinal lines (including 1402 ) and lateral circumferential lines (including 1403 ) that intersect the outer boundaries of the saddle-shaped area.
  • the operator positions the stent so that the aneurysm neck is centered, in each direction, between these radioopaque lines.
  • the saddle-shaped area 1401 is identified by radioopaque longitudinal line 1501 and lateral circumferential line 1502 that intersect the center of the saddle-shaped area.
  • the operator positions the stent so that the intersection of these lines is centered within the aneurysm neck.
  • the radioopaque lines are lateral circumferential and longitudinal lines. In other examples, the radioopaque lines may trace the exact perimeter of the higher-flexibility area.
  • a stent system that is inserted into the parent vessel of an aneurysm in order to reduce blood flow to the aneurysm and promote embolization of the aneurysm” (Nov. 18, 2009 specification, page 10, lines 23-25); “stent wall includes an inner structure . . . that can be expanded from a compressed state to a resilient expanded state and an outer flexible layer . . . that covers . . . part of the inner structure” (Nov. 18, 2009 specification, page 10, lines 25-27); “one area of the outer flexible net . . .
  • the area may span a higher or lower percentage of the surface area of the stent” (Nov. 18, 2009 specification, page 17, line 28-page 18, line 1); “features radioopaque lateral and longitudinal lines that help the operator to align the saddle-shaped area with the aneurysm neck during placement and expansion ” (Nov. 18, 2009 specification, page 17, lines 17-19); “layers may be connected at multiple points or seams” (Nov. 18, 2009 specification, page 13, lines 30-31); and “In this embodiment . . . these layers are not connected to each other” (Nov. 18, 2009 specification, page 13, lines 27-28).
  • an invention can be embodied in a device that is inserted into the parent vessel of an aneurysm in order to reduce blood flow to the aneurysm, comprising: an inner structure that can be expanded from a compressed state to a resilient expanded state within the parent vessel of the aneurysm; and an outer flexible layer that covers part of the inner structure, wherein this outer flexible layer spans a first percentage of the surface area of the inner structure before expansion of the inner structure, wherein this outer flexible layer spans a second percentage of the surface area of the inner structure after expansion of the inner structure, and wherein the first percentage is higher than the second percentage.
  • the outer flexible layer can be less porous than the inner structure.
  • this device can further comprise radioopaque markings that help the operator to align the outer flexible layer with the aneurysm neck.
  • this invention can be embodied in a device that is inserted into the parent vessel of an aneurysm in order to reduce blood flow to the aneurysm, comprising: an inner structure that can be expanded from a compressed state to a resilient expanded state within the parent vessel of the aneurysm; and an outer flexible layer that covers part of the inner structure, wherein the inner structure and outer flexible layer are connected to each other at multiple points or seams, and wherein one or more of these multiple points or seams are disconnected during expansion of the inner structure.
  • the outer flexible layer can be less porous than the inner structure.
  • this device can further comprise radioopaque markings that help the operator to align the outer flexible layer with the aneurysm neck.
  • FIGS. 16 through 24 show three examples of how this invention can be embodied in a device that is inserted into the parent vessel of an aneurysm in order to reduce blood flow to the aneurysm, comprising: an inner structure that can be expanded from a compressed state to a resilient expanded state within the parent vessel of the aneurysm; and an outer flexible layer that spans a first percentage of the circumference of the inner structure before expansion of the inner structure, wherein this outer flexible layer spans a second percentage of the circumference of the inner structure after expansion of the inner structure, and wherein the first percentage is higher than the second percentage.
  • FIGS. 16 through 18 show an example of a stent with a sliding outer flexible layer that is connected to an inner structure along arcuate ribs.
  • FIG. 16 shows a longitudinal cross-sectional view of aneurysm 1601 and a longitudinal cross-sectional view of the parent vessel of the aneurysm.
  • FIG. 16 also shows a longitudinal side view of a device that has been inserted into the parent vessel of aneurysm 1601 .
  • FIG. 16 shows this device after the device has been placed within the parent vessel and after an outer flexible layer ( 1604 ) has been aligned with the neck of the aneurysm, but before an inner structure ( 1602 ) has been expanded.
  • this device comprises: inner structure ( 1602 ) that can be expanded from a compressed state to a resilient expanded state; outer flexible layer ( 1604 ) that spans part of inner structure 1602 ; multiple points or seams (including 1605 and 1606 ) by which outer flexible layer 1604 is connected to inner structure 1602 ; multiple arcuate ribs or tracks 1607 to which the multiple points or seams (including 1605 and 1606 ) are attached; and inflatable member 1603 which is used to expand inner structure 1602 .
  • inner structure 1602 is an expandable resilient tubular mesh.
  • outer flexible layer 1604 is a saddle-shaped net, patch, covering, and/or liner with a lower porosity than inner structure 1602 .
  • outer flexible layer 1604 can have smaller surface pores or openings (as shown in FIGS. 9 through 13 ) and/or be less permeable to blood than inner structure 1602 .
  • outer flexible layer 1604 can be impermeable to blood.
  • outer flexible layer 1604 can have shapes other than a saddle shape.
  • outer flexible layer 1604 can have a semi-tubular shape.
  • outer flexible layer 1604 spans a first percentage of the circumference of inner structure 1602 before expansion of inner structure 1602 . In this example, outer flexible layer 1604 spans (a maximum of) approximately 75% of the circumference of inner structure 1602 before expansion of inner structure 1602 . In other examples, an outer flexible layer can span a pre-expansion percentage of the circumference of the inner structure in the range of 50% to 100%.
  • arcuate ribs or tracks can encircle the entire circumference of inner structure 1602 .
  • arcuate ribs or tracks can partially encircle a portion of the circumference of inner structure 1602 .
  • arcuate ribs or tracks can fully or partially encircle the circumference of inner structure 1602 in a plane which is substantially perpendicular to the longitudinal axis of inner structure 1602 .
  • arcuate ribs or tracks (such as 1607 ) can expand or telescope longer when inner structure 1602 expands.
  • inflatable member 1603 can be a balloon. In an example, inflatable member 1603 can be inflated by filling it with a liquid, such as saline or contrast media. In an example, inflatable member 1603 can be inflated by filling it with a gas, such as carbon dioxide. In an example, this device can further comprise imaging-detectable markings (as shown in FIGS. 14 and 15 ) to help an operator align outer flexible layer 1604 with the neck of the aneurysm. In an example, this device can further comprise radioopaque markings to help an operator align outer flexible layer 1604 with the neck of the aneurysm.
  • this device can further comprise ultrasound-detectable markings to help an operator align outer flexible layer 1604 with the neck of the aneurysm.
  • three-dimensional ultrasound imaging can be used to guide placement of the device and/or to align the outer layer 1604 with the neck of the aneurysm.
  • FIG. 16 shows this device before inner structure 1602 is expanded by expansion of inflatable member 1603 .
  • FIG. 17 shows this same device after inner structure 1602 has been expanded by expansion of inflatable member 1603 .
  • the (maximum) percentage of the surface area of inner structure 1602 which is spanned by outer flexible layer 1604 is smaller after expansion of inner structure 1602 . This is because outer flexible layer 1604 has been expanded less, or not at all, during the expansion of inner structure 1602 .
  • the (maximum) percentage of the circumference of inner structure 1602 which is spanned by outer flexible layer 1604 is smaller after the expansion of inner structure 1602 .
  • outer flexible layer 1604 has been expanded less, or not at all, during the expansion of inner structure 1602 .
  • the post-expansion percentage of the circumference of inner structure 1602 which is spanned by outer flexible layer 1604 is approximately 30%. In an example, this percentage can be in the range of 20% to 60%
  • outer flexible layer 1604 spans a first (pre-expansion) percentage of the circumference of inner structure 1602 before inner structure 1602 is expanded, spans a second (post-expansion) percentage of the circumference of inner structure 1602 after inner structure is expanded, and the first percentage is larger than the second percentage. This is because the surface area of the outer flexible layer 1604 expands less (or not at all) relative to the expansion of inner structure 1602 .
  • This differential expansion of outer flexible layer 1604 vs. inner structure 1602 creates a region of low-porosity over the aneurysm neck. This advantageously helps to block blood flow through the aneurysm without deleteriously blocking blood flow to nearby branching blood vessels (such as the small branching vessel shown on side of the parent vessel which is opposite the aneurysm neck).
  • outer flexible layer 1604 has less expansion (or none at all) compared to the expansion of inner structure 1602 because outer flexible layer 1604 is connected to inner structure 1602 by means of multiple points or seams (such as 1605 and 1606 ) which are able to slide along multiple arcuate ribs or tracks (such as 1607 ) along the circumference of inner structure 1602 .
  • outer flexible layer 1604 does not expand.
  • outer flexible layer 1604 slides on the arcuate ribs or tracks via multiple points or seams (including 1606 ). This is why, in this example, outer flexible layer 1604 (which does not expand) covers a smaller percentage of the surface area of inner structure 1602 (which does expand) after inner structure 1602 has been expanded.
  • inner structure 1602 and outer flexible layer 1604 can be connected at multiple points or seams and one or more of these points or seams can move along the circumference of the inner structure during expansion of the inner structure.
  • inner structure 1602 and outer flexible layer 1604 can be connected at multiple points or seams and one or more of these points or seams can move on a track along the circumference of the inner structure during expansion of the inner structure.
  • a first subset (including 1606 ) of the multiple points or seams can slide along arcuate ribs or tracks (such as 1607 ) when inner structure 1602 expands, but a second subset (including 1605 ) of the multiple points or seams does not slide. Having a first subset (including 1606 ) of multiple points or seams slide allows outer flexible layer 1604 to not expand when inner structure 1602 expands. Having a second subset (including 1605 ) of multiple points or seams which do not slide helps to keep outer flexible layer 1604 properly positioned over the aneurysm neck during expansion of inner structure 1602 .
  • FIG. 18 shows the same device that was shown in FIGS. 16 and 17 , but in a final configuration after inflatable member 1603 has been removed.
  • FIGS. 19 through 21 show an example of a stent with a sliding outer flexible layer that is held onto an inner structure by arcuate ribs.
  • FIG. 19 shows this device before inner structure ( 1602 ) has been expanded.
  • the device shown in FIG. 19 comprises: inner structure ( 1602 ) that can be expanded from a compressed state to a resilient expanded state; outer flexible layer ( 1604 ) that spans part of inner structure 1602 ; multiple arcuate ribs (including 1901 ) outside outer flexible layer 1604 ; and inflatable member 1603 which is used to expand inner structure 1602 .
  • inner structure 1602 is an expandable resilient tubular mesh.
  • outer flexible layer 1604 is again a saddle-shaped net, patch, covering, and/or liner with a lower porosity than inner structure 1602 .
  • FIG. 19 shows this device before inner structure 1602 is expanded.
  • FIG. 20 shows this device after inner structure 1602 has been expanded.
  • FIG. 21 shows this device in a final configuration after inflatable member 1603 has been removed.
  • arcuate ribs are outside outer flexible layer 1604 .
  • arcuate ribs (such as 1901 ) loosely hold outer flexible layer 1604 against inner structure 1602 , but still allow outer flexible layer 1604 to slide around the circumference of inner structure 1602 when inner structure 1602 expands.
  • these arcuate ribs can encircle the entire circumference of inner structure 1602 .
  • these arcuate ribs can partially encircle a portion of the circumference of inner structure 1602 .
  • these arcuate ribs can expand or telescope longer when inner structure 1602 expands.
  • outer flexible layer 1604 is between inner structure 1602 and a plurality of expandable arcuate ribs, wherein these ribs span all or part of the circumference of inner structure, and wherein the outer flexible layer can slide between the inner structure and the expandable arcuate ribs during expansion of the inner structure.
  • a flexible third layer (such as a tubular net or mesh) can serve the same function as arcuate ribs, instead of using arcuate ribs.
  • the wall of the device may be comprised of more than two layers.
  • FIGS. 22 through 24 show an example of a stent with a sliding outer flexible layer that is connected to an inner structure by partially-detachable connections.
  • FIG. 22 shows this device before an inner structure ( 1602 ) has been expanded.
  • the device shown in FIG. 22 comprises: inner structure ( 1602 ) that can be expanded from a compressed state to a resilient expanded state; outer flexible layer ( 1604 ) that spans part of inner structure 1602 ; multiple points or seams (including 2201 and 2202 ) by which outer flexible layer 1604 is connected to inner structure 1602 ; and inflatable member 1603 which is used to expand inner structure 1602 .
  • inner structure 1602 is again an expandable resilient tubular mesh and outer flexible layer 1604 is again a saddle-shaped net, patch, covering, and/or liner with a lower porosity than inner structure 1602 .
  • FIG. 22 shows this device before inner structure 1602 is expanded.
  • FIG. 23 shows this device after inner structure 1602 has been expanded.
  • FIG. 24 shows this device in a final configuration after inflatable member 1603 has been removed.
  • a subset (including 2202 ) of multiple points or seams become disconnected when inner structure 1602 expands.
  • the subset of points or seams (including 2201 ) which remain connected when inner structure 1602 expands help to keep outer flexible layer 1604 positioned over the aneurysm neck.
  • the subset of multiple points or seams (including 2202 ) can become disconnected due to the shearing force of expansion.
  • the subset of multiple points or seams can become disconnected via melting due to the application of an electrical charge.
  • inner structure 1602 and outer flexible layer 1604 can be connected at multiple points or seams, wherein these one or more of these points or seams are disconnected during expansion of the inner structure.
  • this invention can be embodied in a stent to reduce blood flow to an aneurysm comprising: (a) an inner member, wherein this inner member is expanded from a first configuration to a second configuration within the parent vessel of an aneurysm, wherein the circumference of the second configuration is larger than the circumference of the first configuration; and (b) an outer member, wherein this outer member is less porous than the inner member, wherein this outer member covers or surrounds a first percentage of the surface area of the inner member when the inner structure is in the first configuration, wherein this outer member covers or surrounds a second percentage of the surface area of the inner member when the inner structure is in the second configuration, and wherein the second percentage is lower than the first percentage.
  • the second percentage can be at least 10% less than the first percentage.

Abstract

This invention is a stent to reduce blood flow to an aneurysm comprising: (a) an inner member, wherein this inner member is expanded from a first configuration to a second configuration within the parent vessel of an aneurysm, wherein the circumference of the second configuration is larger than the circumference of the first configuration; and (b) an outer member, wherein this outer member is less porous than the inner member, wherein this outer member covers or surrounds a first percentage of the surface area of the inner member when the inner structure is in the first configuration, wherein this outer member covers or surrounds a second percentage of the surface area of the inner member when the inner structure is in the second configuration, and wherein the second percentage less than the first percentage.

Description

    CROSS-REFERENCE TO RELATED APPLICATIONS:
  • This application is a continuation-in-part of U.S. patent application Ser. No. 12/592,116—entitled “Stent with a Net Layer to Embolize an Aneurysm” filed on Nov. 18, 2009 by Robert Connor and Muhammad Tariq Janjua—the entirety of which is incorporated by reference.
  • FEDERALLY SPONSORED RESEARCH: Not Applicable SEQUENCE LISTING OR PROGRAM: Not Applicable BACKGROUND
  • 1. Field of Invention
  • This invention relates to devices to treat aneurysms.
  • 2. Background and Review of Related Art
  • An aneurysm is an abnormal bulging or ballooning of a blood vessel. Rupture of brain aneurysms can cause stroke, death, or disability. Around one-third of people who have a brain aneurysm that ruptures will die within 30 days of the rupture. Of the survivors, around half of them suffer some permanent loss of brain function. Many aneurysms are not identified until they rupture. However, identification of intact aneurysms is increasing due to increased outpatient imaging. Ruptured aneurysms must be treated to stop the bleeding or to prevent re-bleeding. Intact aneurysms may or may not be treated to prevent rupture, depending on their characteristics. Wide neck aneurysms are less prone to rupture, but are harder to treat. In the U.S., it has been estimated that over 10 million people have brain aneurysms and 30,000 people each year have a brain aneurysm that ruptures.
  • Several approaches can be used to treat brain aneurysms. These different approaches can be divided into three categories: (1) approaches involving treatment outside the vessel; (2) approaches involving treatment inside the aneurysm; and (3) approaches involving treatment in the parent vessel. Some of these approaches can be used together. Each of these approaches has some disadvantages, as discussed below.
  • 1. Treatment Outside the Vessel
  • Clipping: Clipping is the application of a small clip to the aneurysm neck from outside the vessel to seal off the aneurysm. For most brain aneurysms, this involves invasive surgery including removing a section of the skull. Clipping began in the 1930's and is well-established. Clipping is more common in the U.S. than in Europe. Around half of all aneurysms are treated by clipping. There are many aneurysm clips in the prior art. However, due to its invasive nature, clipping is decreasing. Potential disadvantages of clipping can include: significant health risks associated with major surgery of this type; and long recovery times, even when the surgery itself goes well.
  • 2. Treatment Inside the Aneurysm
  • Metal Coils: Metal coiling is the endovascular insertion of metal coils into the aneurysm to reduce blood flow and promote embolization in the aneurysm. Historically, metal coils have been platinum. Coils are more common in Europe than in the U.S. There are many examples of metal coils. Potential disadvantages of metal coils can include: low percentage of aneurysm volume filled (low occlusion is associated with a higher risk of rupture); compaction of coils over time; risk of recanalization; potential prolapse of coils into the parent vessel; difficulty later clipping aneurysms filled with metal coils, if needed; pressure from the coils on surrounding brain tissue; inability of coils to treat all aneurysms; and expense of metal coils (especially platinum coils).
  • Combination Metal/Textile/Foam/Gel Coils: Coils with a combination of metal and other materials can be used to try to achieve greater occlusion volume than metal coils alone. These other materials include textile, foam, and gel elements. Textile strands can be woven into the coils to add bulk. Coils can be covered with soft foam. Gel elements can be strung together into elongated structures. Examples of related art that appear to use this approach includes the following: U.S. Pat. Nos. 5,382,259 (Phelps et al.), 5,522,822 (Phelps et al.), 5,690,666 (Berenstein et al.), 5,718,711 (Berenstein et al.), 5,749,894 (Engelson), 5,976,162 (Doan et al.), 6,024,754 (Engelson), 6,299,619 (Greene, Jr. et al.), 6,602,261 (Greene, Jr. et al.), 6,723,108 (Jones et al.), 6,979,344 (Jones et al.), 7,070,609 (West), and 7,491,214 (Greene, Jr. et al.), and U.S. Patent Applications 20040158282 (Jones, Donald et al.), 20050267510 (Razack, Nasser), and 20060058834 (Do, Hiep et al.). Potential disadvantages of combination coils can include: remaining gaps between loops; compaction of coils over time; risk of recanalization; potential prolapse of coils into the parent vessel; difficulty clipping aneurysms filled with coils with metal components later if needed; pressure from the coils on surrounding brain tissue; inability of coils to treat all aneurysms; and expense of metal coils.
  • Inflatable Balloons: Approximately two decades ago, there were numerous efforts to treat aneurysms by permanently filling them with inflatable balloons. These efforts were largely abandoned due to the risks of balloon deflation, prolapse into the parent vessel, aneurysm rupture, and recanalization. There are, however, examples of relatively recent art that appear to use inflatable balloons to treat aneurysms: U.S. Pat. Nos. 6,569,190 (Whalen et al.) and 7,083,643 (Whalen et al.), and U.S. Patent Applications 20030135264 (Whalen et al.), 20030187473 (Berenstein, Alejandro et al.), 20060292206 (Kim, Steven et al.), 20070050008 (Kim, Steven et al.), and 20070055355 (Kim, Steven et al.). Potential disadvantages of using inflatable balloons to permanently fill aneurysms can include: balloon deflation; prolapse of the balloon into the parent vessel; aneurysm rupture due to balloon pressure; and recanalization.
  • Manually-Activated Mesh Occluders: Another approach to treating aneurysms involves inserting into the aneurysm a mesh structure, generally metal, that can be expanded or contracted by human-controlled mechanical motion so as to block the aneurysm neck and/or to fill the main volume of the aneurysm. For example, a wire structure can be inserted through the aneurysm neck in a narrow configuration and then transformed into an “hour-glass” shape that collapses to block the aneurysm neck when activated by a human controller. Examples of related art that appear to use this approach include the following: U.S. Pat. Nos. 5,928,260 (Chin et al.), 6,344,048 (Chin et al.), 6,375,668 (Gifford et al.), 6,454,780 (Wallace), 6,746,468 (Sepetka et al.), 6,780,196 (Chin et al.), and 7,229,461 (Chin et al.), and U.S. Patent Applications 20020042628 (Chin, Yem et al.), 20020169473 (Sepetka, Ivan et al.), 20030083676 (Wallace, Michael), 20030181927 (Wallace, Michael), 20040181253 (Sepetka, Ivan et al.), 20050021077 (Chin et al.), 20060155323 (Porter, Stephen et al.), 20070088387 (Eskridge, Joseph et al.), 20070106311 (Wallace, Michael et al.), and 20080147100 (Wallace, Michael). Potential disadvantages of such manually-activated metal occluders include: difficulty engaging the necks of wide-neck aneurysms; difficulty filling irregularly-shaped aneurysms with standard-shaped mesh structures; risk of rupture when pinching the aneurysm neck or pushing on the aneurysm walls; and protrusion of the proximal portion of “hour-glass” designs into the parent vessel.
  • Self-Expanding Standard-Shape Occluders: Another approach to treating aneurysms uses standard-shaped structures that self-expand when released into the aneurysm. For example, the structure may be a mesh of “shape memory” metal that automatically expands to a standard shape when released from the confines of the catheter walls. As another example, the structure may be a gel that expands to a standard shape when exposed to moisture. Examples of related art that appear to use this approach include the following: U.S. Pat. Nos. 5,766,219 (Horton), 5,916,235 (Guglielmi), 5,941,249 (Maynard), 6,409,749 (Maynard), 6,506,204 (Mazzocchi), 6,605,111 (Bose et al.), 6,613,074 (Mitelberg et al.), 6,802,851 (Jones et al.), 6,811,560 (Jones et al.), 6,855,153 (Saadat), 7,083,632 (Avellanet et al.), 7,306,622 (Jones et al.), and 7,491,214 (Greene, Jr. et al.), and U.S. Patent Applications 20030093097 (Avellanet, Ernesto et al.), 20030195553 (Wallace, Michael et al.), 20050033349 (Jones, Donald et al.), 20060052816 (Bates, Brian et al.), and 20060235464 (Avellanet, Ernesto et al.) and WIPO Patents WO/2006/084077 (Porter, Stephen et al.) and WO/1996/018343 (McGurk et. al.). Potential disadvantages of such self-expanding standard-shape structures can include: risk of prolapse into the parent vessel, especially for wide-neck aneurysms; difficulty occluding irregularly-shaped aneurysms with standard shape structures and associated risk of recanalization; and difficulty generating the proper amount of force (not too much or too little) when engaging the aneurysm walls with a standard-shaped self-expanding structure.
  • Self-Expanding Custom-Modeled Occluders: A variation on self-expanding standard-shape occluders (discussed above) are self-expanding occluders that are custom modeled before insertion so as to fit the shape of a particular aneurysm. As an example sequence—the aneurysm can be imaged, the image is used to custom model the occluding structure, the occluding structure is compressed into a catheter, the occluding structure is inserted into the aneurysm, and the occluding structure then self-expands to fill the aneurysm. The occluding structure may be made from a gel that expands upon contact with moisture. Examples of related art that appear to use this approach include the following: U.S. Pat. Nos. 5,766,219 (Horton), 6,165,193 (Greene, Jr. et al.), 6,500,190 (Greene, Jr. et al.), 7,029,487 (Greene, Jr. et al.), and 7,201,762 (Greene, Jr. et al.), and U.S. Patent Application 20060276831 (Porter, Stephen et al.). Potential disadvantages of self-expanding custom-modeled occluders can include: the complexity and expense of imaging and modeling irregularly-shaped aneurysms; difficulty compressing larger-size structures into a catheter; difficulty inserting the occluding structure in precisely the correct position; and difficulty getting a gelatinous surface to anchor solidly to aneurysm walls.
  • Congealing Liquid or Gel: Another approach to treating aneurysms involves filling an aneurysm with a liquid or gel that congeals rapidly. Examples of related art that appear to use this approach include the following: U.S. Pat. Nos. 6,569,190 (Whalen et al.), 6,626,928 (Raymond et al.), 6,958,061 (Truckai et al.), and 7,083,643 (Whalen et al.), and U.S. Patent Application 20030135264 (Whalen et al.). Potential disadvantages of a congealing liquid or gel can include: leakage of the congealing substance into the parent vessel, potentially causing a stroke; difficulty filling the entire aneurysm if the substance begins to congeal before the aneurysm is full; and seepage of toxic substances into the blood stream.
  • Biological or Pharmaceutical Agents: Biological and/or pharmaceutical agents can enhance the performance of a variety of mechanical treatment methods for aneurysms. For example, they can speed up the natural embolization process to occlude the aneurysm. Examples of related art that appear to use this approach include the following: U.S. Patent Applications 20060206139 (Tekulve, Kurt J.), 20070168011 (LaDuca, Robert et al.), and 20080033341 (Grad, Ygael). Currently, biological and/or pharmaceutical approaches are not sufficient as stand alone treatment approaches for many cases. Accordingly, they share most of the potential disadvantages of the baseline approach to which the biological or pharmaceutical agents are added.
  • Embolic-Emitting Expanding Members: Another approach involves an expanding member within the aneurysm that emits embolic elements into the aneurysm. Examples of such expanding members include bags, meshes, and nets. Examples of embolic elements include coils and congealing liquids. This can be viewed as another way to block the aneurysm neck while delivering embolics into the volume of the aneurysm. For example, the distal portion of an expanding bag may leak embolic elements into the aneurysm, but the proximal portion of the expanding member does not leak embolics into the parent vessel. Examples of related art that appear to use this approach include the following: U.S. Pat. No. 6,547,804 (Porter et al.) and U.S. Patent Applications 20040098027 (Teoh, Clifford et al.), 20060079923 (Chhabra, Manik et al.), and 20080033480 (Hardert, Michael). Potential disadvantages are as follows. Since the expanding member “leaks,” it may have insufficient expansion force to adequately anchor against the aneurysm walls or to seal off the aneurysm neck. As a result of poor anchoring, the bag may prolapse into the parent vessel. Also, as a result of poor sealing of the aneurysm neck, embolics may leak into the parent vessel.
  • Shape Memory Structures inside Expanding Members: A variation on the shape memory approach above involves the addition of an expanding member around the shape memory structure. Examples of related art that appear to use this approach include the following: U.S. Pat. Nos. 5,861,003 (Latson et al.), 6,346,117 (Greenhalgh), 6,350,270 (Roue), 6,391,037 (Greenhalgh), and 6,855,153 (Saadat). The potential disadvantages of this approach are similar to those for uncovered shape memory occluders: risk of prolapse into the parent vessel, especially for wide-neck aneurysms; difficulty occluding irregularly-shaped aneurysms with standard shape structures and associated risk of recanalization; and difficulty generating the proper amount of force (not too much or too little) when engaging the aneurysm walls with a standard-shaped self-expanding structure.
  • Accumulating Coils inside Expanding Members: A variation on the standard coiling approach above involves the addition of an expanding member around the accumulating coils. Examples of related art that appear to use this approach include the following: U.S. Pat. Nos. 5,334,210 (Gianturco), 6,585,748 (Jeffree), and 7,153,323 (Teoh et al.), and U.S. Patent Applications 20060116709 (Sepetka, Ivan et al.), 20060116712 (Sepetka, Ivan et al.), and 20060116713 (Sepetka, Ivan et al.). Potential disadvantages of this approach are similar to those for coils alone, including: compaction of coils over time; risk of recanalization due to “bumpy” coil-filled expanding member; difficulty clipping aneurysms filled with metal coils later if needed; pressure from the coils on surrounding brain tissue; inability to treat all aneurysms; and expense of metal coils (especially platinum coils).
  • 3. Treatment in the Parent Vessel
  • Standard (High-Porosity) Stent: A stent is a structure that is inserted into a vessel in a collapsed form and then expanded into contact with the vessel walls. Standard stents are generally highly porous, metal, and cylindrical. A high-porosity stent allows blood to flow through the stent walls if there are any branching or secondary vessels in the vessel walls. Blood flow through a stent wall into a branching or secondary vessel is desirable, but blood flow through a stent wall into an aneurysm is not. Accordingly, a high-porosity stent in the parent vessel is not a good stand-alone aneurysm treatment. A high-porosity stent in the parent vessel can, however, help to keep coils or other embolic members from escaping out of the aneurysm into the parent vessel.
  • Examples of related art that appear to use this approach include the following: U.S. Pat. Nos. 6,096,034 (Kupiecki et al., 2000), 6,344,041 (Kupiecki et al., 2002), 6,168,592 (Kupiecki et al., 2001), and 7,211,109 (Thompson, 2007). Potential disadvantages of this approach can include many of the problems associated with use of the embolic members alone. For example, using a high-porosity stent in the parent vessel in combination with coils in the aneurysm still leaves the following disadvantages of using coils alone: low percentage of aneurysm volume filled (and low occlusion is associated with a higher risk of rupture); compaction of coils over time; significant risk of recanalization; difficulty clipping aneurysms filled with metal coils later if needed; pressure from the coils on surrounding brain tissue; inability of coils to treat all aneurysms; and expense of metal coils (especially platinum coils).
  • Uniformly Low-Porosity Stent: Another approach involves inserting a uniformly low-porosity stent into the parent vessel. The low-porosity stent blocks the flow of blood through the stent walls into the aneurysm, causing beneficial embolization of the aneurysm. For example, the stent may have one or more layers that are impermeable to the flow of liquid. Unlike a standard (high-porosity) stent, this approach can be used as a stand-alone aneurysm treatment. Examples of related art that appear to use this approach include the following: U.S. Pat. Nos. 5,645,559 (Hachtman et al., 1997), 5,723,004 (Dereume et al., 1998), 5,948,018 (Dereume et al., 1999), 6,165,212 (Dereume et al., 2000), 6,063,111 (Hieshima et al., 2000), 6,270,523 (Herweck et al., 2001), 6,331,191 (Chobotov, 2001), 6,342,068 (Thompson, 2002), 6,428,558 (Jones et al., 2002), 6,656,214 (Fogarty et al., 2003), 6,673,103 (Golds et al., 2004), 6,790,225 (Shannon et al., 2004), and 6,786,920 (Shannon et al., 2004), and U.S. Patent Application 20080319521 (Norris et al., 2008). Potential disadvantages of this approach can include: undesirably blocking blood flow to branching or secondary vessels that are close to the aneurysm and are covered by the stent wall; difficulty achieving a snug fit across the neck of the aneurysm if the parent vessel is curved, twisted, or forked; and poor attachment of the stent with the parent vessel wall due to the impermeable nature of the stent wall.
  • Uniformly Intermediate-Porosity Metal Stent: This approach pursues creation of a stent with a uniform intermediate porosity that provides a compromise between the benefits of a high-porosity stent in the parent vessel (good blood flow to nearby branching or secondary vessels) and the benefits of a low-porosity stents in the parent vessel (blocking blood flow to the aneurysm). Examples of related art that appear to use this approach include the following: U.S. Pat. Nos. 6,770,087 (Layne et al., 2004), 7,052,513 (Thompson, 2006), and 7,306,624 (Yodfat et al., 2007), and U.S. Patent Applications 20070207186 (Scanlon et al.,2007), 20070219619 (Dieck et al., 2007), 20070276470 (Tenne, 2007), 20070276469 (Tenne, 2007), and 20080039933 (Yodfat et al., 2008). The main potential disadvantage of this approach is that it may perform neither function very well. It may unreasonably block flow to a branching or secondary vessels (causing a stroke) and may inadequately block blood flow to the aneurysm (leaving it vulnerable to rupture).
  • Pre-Formed Differential Porosity Stent: This approach involves creating a stent with different levels of porosity for different wall areas, before the stent is inserted into the parent vessel. The goal is two-fold: (1) to place wall areas with high porosity over openings to branching or secondary vessels; and (2) to place wall areas with low porosity over the neck of the aneurysm. Examples of related art that appear to use this approach include the following: U.S. Pat. Nos. 5,769,884 (Solovay,1998), 5,951,599 (McCrory, 1999), 6,309,367 (Boock, 2001), 6,309,413 (Dereume et al., 2001), 6,165,212 (Dereume et al., 2000), 5,948,018 (Dereume et al.,1999), 5,723,004 (Dereume et al., 1998), and 7,186,263 (Golds et al., 2007), and U.S. Patent Applications 20070219610 (Israel, 2007), 20070239261 (Bose, et al., 2007), and 20080004653 (Sherman et al., 2008). Potential disadvantages of this approach include: difficultly matching a specific anatomic configuration (curvature, branching, neck size, etc) with a preformed stent; difficulty of precise placement of the stent to properly align the porous and non-porous areas with branching vessels and the aneurysm, respectively; and difficulty creating low porosity areas in a compressed state that maintain this low porosity in an expanded state.
  • Post-Implantation Filling Between Stent Wall and Vessel Wall: This approach fills the gap between the wall of the stent and the wall of the parent vessel with an embolizing substance such as a liquid or gel that solidifies after insertion. Examples of related art that appear to use this approach include the following: U.S. Pat. Nos. 5,769,882 (Fogarty et al., 1998) and U.S. Patent Application 20070150041 (Evans et al., 2007). Potential disadvantages of this approach include: difficulty injecting the embolizing substance through the stent wall without having it leak back into the parent vessel; leakage of embolizing liquid or gel between the stent and the parent vessel into the blood stream, where it blocks a downstream vessel and causes a stroke; challenges containing the embolic material within curving vessels or vessels with irregular walls; and difficulty using this method to fill narrow-neck aneurysms.
  • Post-Implantation Surface Modification: This approach creates different degrees of porosity in different wall areas after the stent is implanted. The goal is to decrease the porosity of the stent wall in the area of the aneurysm neck, but to leave the rest of the stent wall relatively porous to allow blood flow to branching or secondary members. Also, high porosity in other areas of the stent wall aids in the attachment and integration of the stent to the parent vessel. Unlike the preceding approach, this approach does not fill the gap between the stent wall and the parent vessel wall with some type of solidifying liquid, but rather modifies the wall of the stent itself This reduces the risk of embolic liquid or members leaking out between the stent and the parent vessel wall into the blood stream.
  • This approach remains relatively uncommon The few examples in the related art appear to expose one area of the stent wall to surface-modifying chemicals or energy emissions in order to decrease porosity of the stent wall in that area alone. Examples of related art that appear to use this approach include the following: U.S. Pat. Nos. 5,951,599 (McCrory, 1999) and 7,156,871 (Jones et al., 2007). Potential disadvantages of this approach include: negative effects of surface-modifying chemicals seeping into the blood stream; negative effects of energy emissions on surrounding vessel or brain tissue; and difficulty adding enough matter to the stent wall covering the aneurysm neck by chemical or energy modification means, after stent implantation, to adequately reduce blood flow through the aneurysm neck.
  • To conclude this section, although there has been significant progress in developing options for treating brain aneurysms, there are still high rates of death and disability and still disadvantages to the treatment options available.
  • SUMMARY OF THIS INVENTION
  • This invention can be embodied in a stent system that is inserted into the parent vessel of an aneurysm in order to reduce blood flow to the aneurysm and promote embolization of the aneurysm. The stent wall includes an inner structure, such as an expandable metal mesh, that can be expanded from a compressed state to a resilient expanded state and an outer flexible layer, such as a flexible fabric net, that covers all or part of the inner structure. Embolic members are placed and retained in the gap between the inner structure and the outer layer in the area of the aneurysm neck in order to reduce blood flow to the aneurysm.
  • This invention can also be embodied in a stent to reduce blood flow to an aneurysm comprising: (a) an inner member, wherein this inner member is expanded from a first configuration to a second configuration within the parent vessel of an aneurysm, wherein the circumference of the second configuration is larger than the circumference of the first configuration; and (b) an outer member, wherein this outer member is less porous than the inner member, wherein this outer member covers or surrounds a first percentage of the surface area of the inner member when the inner structure is in the first configuration, wherein this outer member covers or surrounds a second percentage of the surface area of the inner member when the inner structure is in the second configuration, and wherein the second percentage less than the first percentage.
  • INTRODUCTION TO THE FIGURES
  • FIGS. 1 through 24 show possible embodiments of this stent, but do not limit the full generalizability of the claims.
  • FIG. 1 shows an opaque side view of one embodiment of this stent after it has been inserted and expanded within the parent blood vessel of an aneurysm.
  • FIG. 2 shows an alternative view of this same embodiment, with the two layers of the stent being transparent in order to allow a clearer view of the guidewires.
  • FIG. 3 shows an opaque side view of this same embodiment, except that a catheter to deliver embolic members has now been slid along the guidewires to reach an opening in the inner mesh structure.
  • FIG. 4 shows an alternative view of this same embodiment with the two layers of the stent being transparent in order to allow a clearer view of the catheter and the embolic members.
  • FIG. 5 shows an opaque side view of this same embodiment, except that a plurality of embolic members have now been inserted into the gap between the inner mesh structure and the outer flexible layer in the area of the aneurysm neck.
  • FIG. 6 shows an alternative view of this same embodiment with the two layers of the stent being transparent in order to allow a clearer view of the catheter and the embolic members.
  • FIGS. 7 and 8 show this same embodiment after the detachment and withdrawal of the guidewires and catheter.
  • FIG. 9 shows a close-up view of guidewires attached to the inside surface of a hexagonal opening in the inner mesh structure.
  • FIG. 10 shows a close-up view of the distal end of the catheter as it slides along the guidewires toward the inner mesh structure.
  • FIG. 11 shows a close-up view of the distal end of the catheter after it has completely slid along the guidewires to reach the inner mesh structure and be aligned with an opening in this inner mesh structure.
  • FIG. 12 shows a close-up view of embolic members being propelled through the catheter by a flow of sterile saline solution.
  • FIG. 13 shows a close-up view of a plurality of embolic members having been inserted into the gap between the inner mesh structure and the outer flexible layer, with both guidewires and catheter having been withdrawn.
  • FIGS. 14 and 15 show examples of this stent with a high-flexibility area of the outer flexible layer that is identified by radioopaque lines and that is positioned to cover the aneurysm neck.
  • FIGS. 16 through 18 show an example of a stent with a sliding outer flexible layer that is connected to an inner structure along arcuate ribs.
  • FIGS. 19 through 21 show an example of a stent with a sliding outer flexible layer that is held onto an inner structure by arcuate ribs.
  • FIGS. 22 through 24 show an example of a stent with a sliding outer flexible layer that is connected to an inner structure by partially-detachable connections.
  • DETAILED DESCRIPTION OF THE FIGURES
  • FIGS. 1 through 24 show possible embodiments of this stent. However, these embodiments are not exhaustive. These figures do not limit the full generalizability of the claims.
  • FIG. 1 shows an opaque side view of one embodiment of this stent, after it has been inserted and expanded within the parent blood vessel of an aneurysm. FIG. 1 also shows a cross-sectional side view of the parent blood vessel 103 with aneurysm 101 including aneurysm neck 102. In this embodiment, the stent system has a resilient inner structure 104, which is a metal mesh with a hexagonal pattern, and an outer flexible layer 105 that is configured like a net around the inner structure. FIG. 1 also shows two guidewires 106 that are attached to inner structure 104. The stent is shown in FIG. 1 in an already inserted and expanded configuration. Many methods of stent insertion and expansion, such as by catheter and balloon, are well known in the art and the precise methods of insertion and expansion are not central to this invention.
  • In this embodiment, the wall of the stent consists of two layers. The inner layer of the stent wall is an expandable and resilient metal mesh structure 104 with a hexagonal pattern. Many other types of expandable mesh structures may also be used. In various examples, this inner mesh structure may be made from stainless steel, a nickel-titanium alloy, cobalt chromium or a cobalt-chromium alloy, titanium or a titanium alloy, tantalum or a tantalum allow, or polymeric-based resin or another polymer. In this embodiment, the outer layer of the stent is a flexible fabric net 105. In various examples, the outer flexible layer may be made from latex, nylon, polyester, teflon, silicone, HDPE, polycarbonate urethane, polyether-polyamide copolymer, polyethylene terephthalate, polyolefin, polypropylene, polytetrafluorethylene, polytetrafluoroethene, polyurethane, or polyvinyl chloride.
  • In this embodiment, there is a gap between the inner mesh structure and the outer flexible layer and these layers are not connected to each other. In other examples of this invention, there may be no gap between these layers until embolic members are inserted between them in the area of the aneurysm neck. In other examples, the two layers may be connected at multiple points or seams in order to form separate pouches between the layers for more precise localized containment of the embolic members between the layers. In other examples, the wall may be comprised of more than two layers.
  • FIG. 2 shows an alternative view of the same embodiment of this stent that is shown in FIG. 1. FIG. 2 is the same as FIG. 1 except that FIG. 2 shows the two layers of the stent as transparent in order to allow a clearer view of two guidewires 106 that are attached to the inner mesh structure of the stent wall. In this embodiment, these two guidewires 106 were attached to the inner structure of the stent at a specific point before insertion of the stent and the operator has aligned this point with the aneurysm neck 102 during stent placement within the parent vessel 103. In this embodiment, these two guidewires 106 will be used to guide a catheter that delivers embolic members into the gap between the inner wall structure 104 and the outer flexible layer 105. In another example, guidewires need not be used; the catheter may be directed to the inner wall structure using real-time imaging and attached to the inner wall structure with a grasping or hooking mechanism.
  • FIG. 3 shows an opaque side view of the same embodiment of this stent that is shown in FIG. 1, except that a catheter 301 to deliver embolic members (including embolic member 302) has been slid along guidewires 106 to reach an opening in the inner mesh structure 104. In this embodiment, sterile embolic members (including 302) are propelled by a flow of sterile saline solution through catheter 301 for insertion into the gap between inner mesh structure 104 and outer flexible layer 105. The saline solution propels the embolic members through the catheter and into the gap, wherein the members expand and are trapped within the gap. The saline solution escapes through the openings in the mesh. In other examples, other means may be used to transport the embolic members along the catheter, such as miniature conveyor belts or rotating helix mechanisms.
  • In this embodiment, the embolic members are compressible micro-sponges that expand upon ejection from the catheter. In various examples, these micro-sponges may be made from cellulose, collagen, acetate, alginic acid, carboxy methyl cellulose, chitin, collagen glycosaminoglycan, divinylbenzene, ethylene glycol, ethylene glycol dimethylmathacrylate, ethylene vinyl acetate, hyaluronic acid, hydrocarbon polymer, hydroxyethylmethacrylate, methlymethacrylate, polyacrylic acid, polyamides, polyesters, polyolefins, polysaccharides, polyurethane, polyvinyl alcohol, silicone, urethane, and vinyl stearate. In other examples, the embolic members may be gels, beads, or coils.
  • In this embodiment, the embolic members (such as 302) are retained with the gap between the inner mesh structure 104 and outer flexible layer 105 because they expand upon ejection from the catheter 301 and can not exit the same opening in the inner mesh structure by which they entered this gap. In another example, the embolic members need not expand, but the opening by which they enter the gap may be closed when the catheter is removed to trap them within the gap.
  • FIG. 4 shows an alternative view of the same embodiment of this stent that is shown in FIG. 3, except that the two layers of the stent are transparent in order to allow a clearer view of catheter 301 and embolic members (including 302).
  • FIG. 5 shows an opaque side view of the same embodiment of this stent that is shown in FIG. 3, except that a plurality of embolic members (including 302) have now been delivered via catheter 301 and inserted into the gap between the inner mesh structure 104 and the outer flexible layer 105 in the area of the aneurysm neck. The flexibility of outer layer 105 allows it to distend into the aneurysm neck to more thoroughly block blood flow through the neck. A sufficient volume of embolic members has been inserted into this gap in the area of the aneurysm neck to occlude the flow of blood into aneurysm 101, thereby promoting embolization of the aneurysm.
  • FIG. 6 shows an alternative view of the same embodiment of this stent that is shown in FIG. 5, except that the two layers of the stent are transparent in order to allow a clearer view of catheter 301 and embolic members (including 302).
  • FIGS. 7 and 8 show the same embodiment, but after the detachment and withdrawal of the guidewires 106 and catheter 301. In this example, the guidewires may be detached from the inner mesh structure by application of a mild electric current and the catheter may be removed by simple mechanical withdrawal. Many other methods for detaching and removing guidewires and catheters are known in the prior art and the exact detachment and removal mechanisms are not central to this invention. Blood flow through the aneurysm neck is now largely blocked to promote embolization of the aneurysm, but other areas of the stent remain largely porous to foster integration with the walls of the parent vessel and to allow blood flow to any secondary vessels that may branch off from the parent vessel along the length of the stent.
  • FIGS. 9 through 13 show greater detail for one example of how the guidewires and catheter function to transport embolic members into the gap between the inner mesh structure and the outer flexible layer of the stent wall. In these figures: only small square patches of inner mesh structure 104 and outer flexible layer 105 are shown (indicated by dashed line borders); and the size of the gap between these two layers is exaggerated to provide a clearer view of how embolic members are inserted within this gap. In this example, guidewires 106 are attached to inner mesh structure 104 before the stent is inserted in the parent vessel and catheter 301 is guided to the inner mesh structure 104 by means of these guidewires.
  • FIG. 9 shows a close-up view of guidewires 106 attached to the inside surface of a hexagonal opening in inner mesh structure 104. FIG. 9 also shows outer flexible layer 105. FIG. 9 corresponds to a close-up view of a small area of FIGS. 1 and 2, the area in which guidewires 106 are attached to inner mesh structure 104. FIG. 10 shows a close-up view of the distal end 1001 of catheter 301 as it slides along guidewires 106 toward inner mesh structure 104. The other (proximal) end of catheter 301 remains outside the person's body. There are two holes, including 1002, that run longitudinally through opposite sides of the wall of catheter 301 and contain guidewires 106, enabling catheter 301 to slide along guidewires 106. FIG. 11 shows a close-up view of the distal end 1001 of catheter 301 after it has completely slid along guidewires 106 to reach inner mesh structure 104 and be aligned with one hexagonal opening of this structure.
  • FIG. 12 shows a close-up view of embolic members (including 302) being propelled through catheter 301 by a flow of sterile saline solution. In this example, the embolic members are micro-sponges that expand upon ejection from the catheter into the gap between the inner mesh structure 104 and outer flexible layer 105. FIG. 12 corresponds to a close-up view of a small area of FIGS. 3 and 4, the area in which the guidewires 106 are attached to the inner mesh structure 104.
  • FIG. 13 shows a close-up view of a plurality of embolic members having been inserted into the gap between the inner mesh structure 104 and outer flexible layer 105. Also, guidewires 106 and catheter 301 have been detached and withdrawn. FIG. 13 corresponds to a close-up view of a small area of FIGS. 7 and 8, the area in which the guidewires were attached to the inner mesh structure.
  • FIGS. 14 and 15 show an opaque side view of two examples of this stent that feature an outer flexible layer with differential flexibility. Having a stent with one area of the outer flexible layer that has greater flexibility and placing this area over the aneurysm neck has two advantages. First, it facilitates insertion of a substantial mass of embolic members into the gap between the inner mesh and the outer flexible layer in the area of the aneurysm neck in order to thoroughly occlude the aneurysm neck. Second, although the walls of the parent vessel resist migration of embolic members through the gap away from the aneurysm neck area, having less flexibility of the outer layer outside the aneurysm neck area provides additional resistance to possible migration of embolic members.
  • Specifically, FIGS. 14 and 15 show a stent, with an inner structural mesh 104 and an outer flexible net 105, having been inserted into parent vessel 103 of aneurysm 101 with aneurysm neck 102. FIGS. 14 and 15 also show a saddle-shaped area 1401 of the outer flexible net that has greater flexibility than the rest of the net. This saddle-shaped area with greater flexibility is positioned to cover the aneurysm neck when the stent is placed and expanded.
  • In FIGS. 14 and 15, the stent also features radioopaque lateral and longitudinal lines that help the operator to align the saddle-shaped area with the aneurysm neck during placement and expansion of the stent. In FIG. 14, the saddle-shaped area 1401 is identified for the operator by radioopaque longitudinal lines (including 1402) and lateral circumferential lines (including 1403) that intersect the outer boundaries of the saddle-shaped area. In this example, the operator positions the stent so that the aneurysm neck is centered, in each direction, between these radioopaque lines. In FIG. 15, the saddle-shaped area 1401 is identified by radioopaque longitudinal line 1501 and lateral circumferential line 1502 that intersect the center of the saddle-shaped area. In this example, the operator positions the stent so that the intersection of these lines is centered within the aneurysm neck.
  • In the examples shown in FIGS. 14 and 15: there is only one area of the outer flexible net with higher flexibility, this area is saddle-shaped, and this area spans approximately 15% of surface area of the stent. In other examples: there may be more than one area with higher flexibility to address multiple aneurysms, the area may have a different shape, and the area may span a higher or lower percentage of the surface area of the stent. In these examples, the radioopaque lines are lateral circumferential and longitudinal lines. In other examples, the radioopaque lines may trace the exact perimeter of the higher-flexibility area.
  • The following are particularly-relevant quotes from the specification thus far (including page and line numbers from the original Nov. 18, 2009 specification): “a stent system that is inserted into the parent vessel of an aneurysm in order to reduce blood flow to the aneurysm and promote embolization of the aneurysm” (Nov. 18, 2009 specification, page 10, lines 23-25); “stent wall includes an inner structure . . . that can be expanded from a compressed state to a resilient expanded state and an outer flexible layer . . . that covers . . . part of the inner structure” (Nov. 18, 2009 specification, page 10, lines 25-27); “one area of the outer flexible net . . . the area may span a higher or lower percentage of the surface area of the stent” (Nov. 18, 2009 specification, page 17, line 28-page 18, line 1); “features radioopaque lateral and longitudinal lines that help the operator to align the saddle-shaped area with the aneurysm neck during placement and expansion ” (Nov. 18, 2009 specification, page 17, lines 17-19); “layers may be connected at multiple points or seams” (Nov. 18, 2009 specification, page 13, lines 30-31); and “In this embodiment . . . these layers are not connected to each other” (Nov. 18, 2009 specification, page 13, lines 27-28).
  • In an example, an invention can be embodied in a device that is inserted into the parent vessel of an aneurysm in order to reduce blood flow to the aneurysm, comprising: an inner structure that can be expanded from a compressed state to a resilient expanded state within the parent vessel of the aneurysm; and an outer flexible layer that covers part of the inner structure, wherein this outer flexible layer spans a first percentage of the surface area of the inner structure before expansion of the inner structure, wherein this outer flexible layer spans a second percentage of the surface area of the inner structure after expansion of the inner structure, and wherein the first percentage is higher than the second percentage. In an example, the outer flexible layer can be less porous than the inner structure. In an example, this device can further comprise radioopaque markings that help the operator to align the outer flexible layer with the aneurysm neck.
  • In an example, this invention can be embodied in a device that is inserted into the parent vessel of an aneurysm in order to reduce blood flow to the aneurysm, comprising: an inner structure that can be expanded from a compressed state to a resilient expanded state within the parent vessel of the aneurysm; and an outer flexible layer that covers part of the inner structure, wherein the inner structure and outer flexible layer are connected to each other at multiple points or seams, and wherein one or more of these multiple points or seams are disconnected during expansion of the inner structure. In an example, the outer flexible layer can be less porous than the inner structure. In an example, this device can further comprise radioopaque markings that help the operator to align the outer flexible layer with the aneurysm neck.
  • FIGS. 16 through 24 show three examples of how this invention can be embodied in a device that is inserted into the parent vessel of an aneurysm in order to reduce blood flow to the aneurysm, comprising: an inner structure that can be expanded from a compressed state to a resilient expanded state within the parent vessel of the aneurysm; and an outer flexible layer that spans a first percentage of the circumference of the inner structure before expansion of the inner structure, wherein this outer flexible layer spans a second percentage of the circumference of the inner structure after expansion of the inner structure, and wherein the first percentage is higher than the second percentage.
  • FIGS. 16 through 18 show an example of a stent with a sliding outer flexible layer that is connected to an inner structure along arcuate ribs. FIG. 16 shows a longitudinal cross-sectional view of aneurysm 1601 and a longitudinal cross-sectional view of the parent vessel of the aneurysm. FIG. 16 also shows a longitudinal side view of a device that has been inserted into the parent vessel of aneurysm 1601. FIG. 16 shows this device after the device has been placed within the parent vessel and after an outer flexible layer (1604) has been aligned with the neck of the aneurysm, but before an inner structure (1602) has been expanded. In this example, this device comprises: inner structure (1602) that can be expanded from a compressed state to a resilient expanded state; outer flexible layer (1604) that spans part of inner structure 1602; multiple points or seams (including 1605 and 1606) by which outer flexible layer 1604 is connected to inner structure 1602; multiple arcuate ribs or tracks 1607 to which the multiple points or seams (including 1605 and 1606) are attached; and inflatable member 1603 which is used to expand inner structure 1602.
  • In this example, inner structure 1602 is an expandable resilient tubular mesh. In this example, outer flexible layer 1604 is a saddle-shaped net, patch, covering, and/or liner with a lower porosity than inner structure 1602. In an example, outer flexible layer 1604 can have smaller surface pores or openings (as shown in FIGS. 9 through 13) and/or be less permeable to blood than inner structure 1602. In an example, outer flexible layer 1604 can be impermeable to blood. In various examples, outer flexible layer 1604 can have shapes other than a saddle shape. In an example, outer flexible layer 1604 can have a semi-tubular shape. In this example, outer flexible layer 1604 spans a first percentage of the circumference of inner structure 1602 before expansion of inner structure 1602. In this example, outer flexible layer 1604 spans (a maximum of) approximately 75% of the circumference of inner structure 1602 before expansion of inner structure 1602. In other examples, an outer flexible layer can span a pre-expansion percentage of the circumference of the inner structure in the range of 50% to 100%.
  • In an example, arcuate ribs or tracks (such as 1607) can encircle the entire circumference of inner structure 1602. In an example, arcuate ribs or tracks (such as 1607) can partially encircle a portion of the circumference of inner structure 1602. In an example, arcuate ribs or tracks can fully or partially encircle the circumference of inner structure 1602 in a plane which is substantially perpendicular to the longitudinal axis of inner structure 1602. In an example, arcuate ribs or tracks (such as 1607) can expand or telescope longer when inner structure 1602 expands.
  • In an example, inflatable member 1603 can be a balloon. In an example, inflatable member 1603 can be inflated by filling it with a liquid, such as saline or contrast media. In an example, inflatable member 1603 can be inflated by filling it with a gas, such as carbon dioxide. In an example, this device can further comprise imaging-detectable markings (as shown in FIGS. 14 and 15) to help an operator align outer flexible layer 1604 with the neck of the aneurysm. In an example, this device can further comprise radioopaque markings to help an operator align outer flexible layer 1604 with the neck of the aneurysm. In an example, this device can further comprise ultrasound-detectable markings to help an operator align outer flexible layer 1604 with the neck of the aneurysm. In an example, three-dimensional ultrasound imaging can be used to guide placement of the device and/or to align the outer layer 1604 with the neck of the aneurysm.
  • FIG. 16 shows this device before inner structure 1602 is expanded by expansion of inflatable member 1603. FIG. 17 shows this same device after inner structure 1602 has been expanded by expansion of inflatable member 1603. As shown in FIG. 17, the (maximum) percentage of the surface area of inner structure 1602 which is spanned by outer flexible layer 1604 is smaller after expansion of inner structure 1602. This is because outer flexible layer 1604 has been expanded less, or not at all, during the expansion of inner structure 1602. As also shown in FIG. 17, the (maximum) percentage of the circumference of inner structure 1602 which is spanned by outer flexible layer 1604 is smaller after the expansion of inner structure 1602. This is because outer flexible layer 1604 has been expanded less, or not at all, during the expansion of inner structure 1602. In this example, the post-expansion percentage of the circumference of inner structure 1602 which is spanned by outer flexible layer 1604 is approximately 30%. In an example, this percentage can be in the range of 20% to 60%
  • As shown in FIGS. 16 and 17, outer flexible layer 1604 spans a first (pre-expansion) percentage of the circumference of inner structure 1602 before inner structure 1602 is expanded, spans a second (post-expansion) percentage of the circumference of inner structure 1602 after inner structure is expanded, and the first percentage is larger than the second percentage. This is because the surface area of the outer flexible layer 1604 expands less (or not at all) relative to the expansion of inner structure 1602. This differential expansion of outer flexible layer 1604 vs. inner structure 1602 creates a region of low-porosity over the aneurysm neck. This advantageously helps to block blood flow through the aneurysm without deleteriously blocking blood flow to nearby branching blood vessels (such as the small branching vessel shown on side of the parent vessel which is opposite the aneurysm neck).
  • In the example shown in FIGS. 16 and 17, outer flexible layer 1604 has less expansion (or none at all) compared to the expansion of inner structure 1602 because outer flexible layer 1604 is connected to inner structure 1602 by means of multiple points or seams (such as 1605 and 1606) which are able to slide along multiple arcuate ribs or tracks (such as 1607) along the circumference of inner structure 1602. In this example, when inner structure 1602 is expanded, outer flexible layer 1604 does not expand. In this example, when inner structure 1602 is expanded, outer flexible layer 1604 slides on the arcuate ribs or tracks via multiple points or seams (including 1606). This is why, in this example, outer flexible layer 1604 (which does not expand) covers a smaller percentage of the surface area of inner structure 1602 (which does expand) after inner structure 1602 has been expanded.
  • In an example, inner structure 1602 and outer flexible layer 1604 can be connected at multiple points or seams and one or more of these points or seams can move along the circumference of the inner structure during expansion of the inner structure. In an example, inner structure 1602 and outer flexible layer 1604 can be connected at multiple points or seams and one or more of these points or seams can move on a track along the circumference of the inner structure during expansion of the inner structure.
  • In the example shown in FIGS. 16 and 17, a first subset (including 1606) of the multiple points or seams can slide along arcuate ribs or tracks (such as 1607) when inner structure 1602 expands, but a second subset (including 1605) of the multiple points or seams does not slide. Having a first subset (including 1606) of multiple points or seams slide allows outer flexible layer 1604 to not expand when inner structure 1602 expands. Having a second subset (including 1605) of multiple points or seams which do not slide helps to keep outer flexible layer 1604 properly positioned over the aneurysm neck during expansion of inner structure 1602. FIG. 18 shows the same device that was shown in FIGS. 16 and 17, but in a final configuration after inflatable member 1603 has been removed.
  • FIGS. 19 through 21 show an example of a stent with a sliding outer flexible layer that is held onto an inner structure by arcuate ribs. FIG. 19 shows this device before inner structure (1602) has been expanded. The device shown in FIG. 19 comprises: inner structure (1602) that can be expanded from a compressed state to a resilient expanded state; outer flexible layer (1604) that spans part of inner structure 1602; multiple arcuate ribs (including 1901) outside outer flexible layer 1604; and inflatable member 1603 which is used to expand inner structure 1602. Similar to the previous example, inner structure 1602 is an expandable resilient tubular mesh. Also, outer flexible layer 1604 is again a saddle-shaped net, patch, covering, and/or liner with a lower porosity than inner structure 1602. FIG. 19 shows this device before inner structure 1602 is expanded. FIG. 20 shows this device after inner structure 1602 has been expanded. FIG. 21 shows this device in a final configuration after inflatable member 1603 has been removed.
  • However, in this example, arcuate ribs (such as 1901) are outside outer flexible layer 1604. In this example, arcuate ribs (such as 1901) loosely hold outer flexible layer 1604 against inner structure 1602, but still allow outer flexible layer 1604 to slide around the circumference of inner structure 1602 when inner structure 1602 expands. In an example, these arcuate ribs can encircle the entire circumference of inner structure 1602. In an example, these arcuate ribs can partially encircle a portion of the circumference of inner structure 1602. In an example, these arcuate ribs can expand or telescope longer when inner structure 1602 expands. In an example, outer flexible layer 1604 is between inner structure 1602 and a plurality of expandable arcuate ribs, wherein these ribs span all or part of the circumference of inner structure, and wherein the outer flexible layer can slide between the inner structure and the expandable arcuate ribs during expansion of the inner structure. In an alternative example, the use of a flexible third layer (such as a tubular net or mesh) can serve the same function as arcuate ribs, instead of using arcuate ribs. In an example, the wall of the device may be comprised of more than two layers.
  • FIGS. 22 through 24 show an example of a stent with a sliding outer flexible layer that is connected to an inner structure by partially-detachable connections. FIG. 22 shows this device before an inner structure (1602) has been expanded. The device shown in FIG. 22 comprises: inner structure (1602) that can be expanded from a compressed state to a resilient expanded state; outer flexible layer (1604) that spans part of inner structure 1602; multiple points or seams (including 2201 and 2202) by which outer flexible layer 1604 is connected to inner structure 1602; and inflatable member 1603 which is used to expand inner structure 1602. Similar to the previous example, inner structure 1602 is again an expandable resilient tubular mesh and outer flexible layer 1604 is again a saddle-shaped net, patch, covering, and/or liner with a lower porosity than inner structure 1602. FIG. 22 shows this device before inner structure 1602 is expanded. FIG. 23 shows this device after inner structure 1602 has been expanded. FIG. 24 shows this device in a final configuration after inflatable member 1603 has been removed.
  • In this example, a subset (including 2202) of multiple points or seams (including 2201 and 2202) become disconnected when inner structure 1602 expands. This is another way to allow inner structure 1602 to expand without making outer flexible layer 1604 also expand. The subset of points or seams (including 2201) which remain connected when inner structure 1602 expands help to keep outer flexible layer 1604 positioned over the aneurysm neck. This is another way to create a low-porosity region over the aneurysm neck to block blood flow to the aneurysm without blocking blood flow to nearby branching vessels. In an example, the subset of multiple points or seams (including 2202) can become disconnected due to the shearing force of expansion. In an example, the subset of multiple points or seams (including 2202) can become disconnected via melting due to the application of an electrical charge. In an example, inner structure 1602 and outer flexible layer 1604 can be connected at multiple points or seams, wherein these one or more of these points or seams are disconnected during expansion of the inner structure.
  • In an example, this invention can be embodied in a stent to reduce blood flow to an aneurysm comprising: (a) an inner member, wherein this inner member is expanded from a first configuration to a second configuration within the parent vessel of an aneurysm, wherein the circumference of the second configuration is larger than the circumference of the first configuration; and (b) an outer member, wherein this outer member is less porous than the inner member, wherein this outer member covers or surrounds a first percentage of the surface area of the inner member when the inner structure is in the first configuration, wherein this outer member covers or surrounds a second percentage of the surface area of the inner member when the inner structure is in the second configuration, and wherein the second percentage is lower than the first percentage. In an example, the second percentage can be at least 10% less than the first percentage.

Claims (20)

We claim:
1. (canceled)
2. (canceled)
3. The device in claim 1 further comprising radioopaque markings that help the operator to align the outer flexible layer with the aneurysm neck.
4. The device in claim 1 further comprising ultrasound-detectable markings that help the operator to align the outer flexible layer with the aneurysm neck.
5. The device in claim 1 wherein the device is guided during placement in the parent vessel using 3D ultrasound.
6. (canceled)
7. (canceled)
8. The device in claim 6 further comprising radioopaque markings that help the operator to align the outer flexible layer with the aneurysm neck.
9. The device in claim 6 further comprising ultrasound-detectable markings that help the operator to align the outer flexible layer with the aneurysm neck.
10. The device in claim 6 wherein the device is guided during placement in the parent vessel using 3D ultrasound.
11. (canceled)
12. (canceled)
13. The device in claim 11 further comprising radioopaque markings that help a user to align the outer member with the aneurysm neck.
14. The device in claim 11 further comprising ultrasound-detectable markings that help a user to align the outer member with the aneurysm neck.
15. The device in claim 11 wherein the device is guided using 3D ultrasound.
16. (canceled)
17. (canceled)
18. The device in claim 11 wherein the inner member and the outer member are connected at multiple points or seams and wherein these one or more of these points or seams are disconnected during expansion of the inner member.
19. A stent to reduce blood flow to an aneurysm comprising:
(a) an inner member, wherein this inner member is expanded from a first configuration to a second configuration within the parent vessel of an aneurysm, wherein the circumference of the second configuration is larger than the circumference of the first configuration; and
(b) an outer member, wherein this outer member is less porous than the inner member, wherein this outer member covers or surrounds a first percentage of the surface area of the inner member when the inner structure is in the first configuration, wherein this outer member covers or surrounds a second percentage of the surface area of the inner member when the inner structure is in the second configuration, wherein the second percentage is lower than the first percentage, wherein the outer member is between the inner member and a plurality of expandable arcuate ribs, wherein these ribs span all or part of the circumference of inner member, and wherein the outer member can slide between the inner member and the expandable arcuate ribs during expansion of the inner member.
20. (canceled)
US14/562,725 2009-11-18 2014-12-07 Stent with outer member to embolize an aneurysm Expired - Fee Related US9358140B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US14/562,725 US9358140B1 (en) 2009-11-18 2014-12-07 Stent with outer member to embolize an aneurysm

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12/592,116 US20100131002A1 (en) 2008-11-24 2009-11-18 Stent with a net layer to embolize and aneurysm
US14/562,725 US9358140B1 (en) 2009-11-18 2014-12-07 Stent with outer member to embolize an aneurysm

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US12/592,116 Continuation-In-Part US20100131002A1 (en) 2008-11-24 2009-11-18 Stent with a net layer to embolize and aneurysm

Publications (2)

Publication Number Publication Date
US20160151177A1 true US20160151177A1 (en) 2016-06-02
US9358140B1 US9358140B1 (en) 2016-06-07

Family

ID=56078439

Family Applications (1)

Application Number Title Priority Date Filing Date
US14/562,725 Expired - Fee Related US9358140B1 (en) 2009-11-18 2014-12-07 Stent with outer member to embolize an aneurysm

Country Status (1)

Country Link
US (1) US9358140B1 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20150216684A1 (en) * 2012-08-17 2015-08-06 The Regents Of The University Of California Dual rotational stent apparatus and method for endovascular treatment of aneurysms
US20160220396A1 (en) * 2011-09-09 2016-08-04 Isis Innovation Limited Stent and method of inserting a stent into a delivery catheter
EP4138741A4 (en) * 2020-04-20 2023-12-27 Exovitra LLC Methods and systems for treatment of aneurysms

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3051684C (en) 2011-12-06 2020-06-16 Aortic Innovations Llc Device for endovascular aortic repair and method of using the same
EP3668417B1 (en) 2017-08-17 2022-10-05 Arissa Medical, Inc. Flow attenuation device
WO2019195540A2 (en) 2018-04-04 2019-10-10 Incumedx, Inc. Embolic device with improved neck coverage

Family Cites Families (659)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4364392A (en) 1980-12-04 1982-12-21 Wisconsin Alumni Research Foundation Detachable balloon catheter
US4958634A (en) 1987-05-06 1990-09-25 Jang G David Limacon geometry balloon angioplasty catheter systems and method of making same
US4994069A (en) 1988-11-02 1991-02-19 Target Therapeutics Vaso-occlusion coil and method
US5405379A (en) 1990-07-26 1995-04-11 Lane; Rodney J. Self expanding vascular endoprosthesis for aneurysms
IT9084979A1 (en) 1990-07-30 1992-01-31 Imad Sheiban PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTIC CATHETER WITH TWO BALLOONS AT ITS DISTAL END ONE OF SMALL DIAMETER (1, 5MM. FOLLOWED BY ANOTHER BALLOON OF GREATER DIAMETER VARIABLE FROM 2, 5 TO 4 MM THE BALLOON THE SMALL BALLOON
JP3356447B2 (en) 1991-10-16 2002-12-16 テルモ株式会社 Vascular lesion embolic material composed of dried polymer gel
ATE247435T1 (en) 1992-05-08 2003-09-15 Schneider Usa Inc STENT FOR THE OESOPHAGUS
US5443478A (en) 1992-09-02 1995-08-22 Board Of Regents, The University Of Texas System Multi-element intravascular occlusion device
US5350397A (en) 1992-11-13 1994-09-27 Target Therapeutics, Inc. Axially detachable embolic coil assembly
US5382259A (en) 1992-10-26 1995-01-17 Target Therapeutics, Inc. Vasoocclusion coil with attached tubular woven or braided fibrous covering
US5690666A (en) 1992-11-18 1997-11-25 Target Therapeutics, Inc. Ultrasoft embolism coils and process for using them
US5370691A (en) 1993-01-26 1994-12-06 Target Therapeutics, Inc. Intravascular inflatable stent
US5334210A (en) 1993-04-09 1994-08-02 Cook Incorporated Vascular occlusion assembly
US5925059A (en) 1993-04-19 1999-07-20 Target Therapeutics, Inc. Detachable embolic coil assembly
US5800453A (en) 1993-04-19 1998-09-01 Target Therapeutics, Inc. Detachable embolic coil assembly using interlocking hooks and slots
US5411549A (en) 1993-07-13 1995-05-02 Scimed Life Systems, Inc. Selectively expandable, retractable and removable stent
US6025044A (en) 1993-08-18 2000-02-15 W. L. Gore & Associates, Inc. Thin-wall polytetrafluoroethylene tube
US5723004A (en) 1993-10-21 1998-03-03 Corvita Corporation Expandable supportive endoluminal grafts
US5423829A (en) 1993-11-03 1995-06-13 Target Therapeutics, Inc. Electrolytically severable joint for endovascular embolic devices
US5624449A (en) 1993-11-03 1997-04-29 Target Therapeutics Electrolytically severable joint for endovascular embolic devices
WO1995013033A1 (en) 1993-11-08 1995-05-18 Lazarus Harrison M Intraluminal vascular graft and method
US5795331A (en) 1994-01-24 1998-08-18 Micro Therapeutics, Inc. Balloon catheter for occluding aneurysms of branch vessels
US6140452A (en) 1994-05-06 2000-10-31 Advanced Bio Surfaces, Inc. Biomaterial for in situ tissue repair
US5536252A (en) 1994-10-28 1996-07-16 Intelliwire, Inc. Angioplasty catheter with multiple coaxial balloons
IL116561A0 (en) 1994-12-30 1996-03-31 Target Therapeutics Inc Severable joint for detachable devices placed within the body
US6579314B1 (en) 1995-03-10 2003-06-17 C.R. Bard, Inc. Covered stent with encapsulated ends
US5911731A (en) 1995-04-20 1999-06-15 Target Therapeutics, Inc. Anatomically shaped vasoocclusive devices
US5645558A (en) 1995-04-20 1997-07-08 Medical University Of South Carolina Anatomically shaped vasoocclusive device and method of making the same
US5639277A (en) 1995-04-28 1997-06-17 Target Therapeutics, Inc. Embolic coils with offset helical and twisted helical shapes
US6143007A (en) 1995-04-28 2000-11-07 Target Therapeutics, Inc. Method for making an occlusive device
US5833657A (en) 1995-05-30 1998-11-10 Ethicon, Inc. Single-walled balloon catheter with non-linear compliance characteristic
US5624461A (en) 1995-06-06 1997-04-29 Target Therapeutics, Inc. Three dimensional in-filling vaso-occlusive coils
US5766160A (en) 1995-06-06 1998-06-16 Target Therapeutics, Inc. Variable stiffness coils
NO962336L (en) 1995-06-06 1996-12-09 Target Therapeutics Inc Vaso-occlusive spiral
US5603722A (en) 1995-06-06 1997-02-18 Quanam Medical Corporation Intravascular stent
US5582619A (en) 1995-06-30 1996-12-10 Target Therapeutics, Inc. Stretch resistant vaso-occlusive coils
DK0754435T3 (en) 1995-06-30 2000-11-27 Target Therapeutics Inc Stretch-resistant co-occlusion spirals
US5853418A (en) 1995-06-30 1998-12-29 Target Therapeutics, Inc. Stretch resistant vaso-occlusive coils (II)
US6013084A (en) 1995-06-30 2000-01-11 Target Therapeutics, Inc. Stretch resistant vaso-occlusive coils (II)
US5743905A (en) 1995-07-07 1998-04-28 Target Therapeutics, Inc. Partially insulated occlusion device
US5785679A (en) 1995-07-19 1998-07-28 Endotex Interventional Systems, Inc. Methods and apparatus for treating aneurysms and arterio-venous fistulas
US5888546A (en) 1995-08-28 1999-03-30 The Regents Of The University Of California Embolic material for endovascular occlusion of abnormal vasculature and method for using the same
US5769882A (en) 1995-09-08 1998-06-23 Medtronic, Inc. Methods and apparatus for conformably sealing prostheses within body lumens
US6689162B1 (en) 1995-10-11 2004-02-10 Boston Scientific Scimed, Inc. Braided composite prosthesis
EP0775471B1 (en) 1995-11-27 2002-05-29 Schneider (Europe) GmbH A stent for use in a body passage way
US6579305B1 (en) 1995-12-07 2003-06-17 Medtronic Ave, Inc. Method and apparatus for delivery deployment and retrieval of a stent comprising shape-memory material
US5749894A (en) 1996-01-18 1998-05-12 Target Therapeutics, Inc. Aneurysm closure method
US6428571B1 (en) 1996-01-22 2002-08-06 Scimed Life Systems, Inc. Self-sealing PTFE vascular graft and manufacturing methods
US6168622B1 (en) 1996-01-24 2001-01-02 Microvena Corporation Method and apparatus for occluding aneurysms
US5702361A (en) 1996-01-31 1997-12-30 Micro Therapeutics, Inc. Method for embolizing blood vessels
US5733294A (en) 1996-02-28 1998-03-31 B. Braun Medical, Inc. Self expanding cardiovascular occlusion device, method of using and method of making the same
US6796997B1 (en) 1996-03-05 2004-09-28 Evysio Medical Devices Ulc Expandable stent
US5649949A (en) 1996-03-14 1997-07-22 Target Therapeutics, Inc. Variable cross-section conical vasoocclusive coils
US5868780A (en) 1996-03-22 1999-02-09 Lashinski; Robert D. Stents for supporting lumens in living tissue
NZ331269A (en) 1996-04-10 2000-01-28 Advanced Cardiovascular System Expandable stent, its structural strength varying along its length
US5718159A (en) 1996-04-30 1998-02-17 Schneider (Usa) Inc. Process for manufacturing three-dimensional braided covered stent
US6592617B2 (en) 1996-04-30 2003-07-15 Boston Scientific Scimed, Inc. Three-dimensional braided covered stent
US6190402B1 (en) 1996-06-21 2001-02-20 Musc Foundation For Research Development Insitu formable and self-forming intravascular flow modifier (IFM) and IFM assembly for deployment of same
US5769884A (en) 1996-06-27 1998-06-23 Cordis Corporation Controlled porosity endovascular implant
US5928279A (en) 1996-07-03 1999-07-27 Baxter International Inc. Stented, radially expandable, tubular PTFE grafts
US5980514A (en) 1996-07-26 1999-11-09 Target Therapeutics, Inc. Aneurysm closure device assembly
US6096034A (en) 1996-07-26 2000-08-01 Target Therapeutics, Inc. Aneurysm closure device assembly
US6123712A (en) 1996-08-23 2000-09-26 Scimed Life Systems, Inc. Balloon catheter with stent securement means
US5968069A (en) 1996-08-23 1999-10-19 Scimed Life Systems, Inc. Stent delivery system having stent securement apparatus
US5964797A (en) 1996-08-30 1999-10-12 Target Therapeutics, Inc. Electrolytically deployable braided vaso-occlusion device
US5941249A (en) 1996-09-05 1999-08-24 Maynard; Ronald S. Distributed activator for a two-dimensional shape memory alloy
US6254628B1 (en) 1996-12-09 2001-07-03 Micro Therapeutics, Inc. Intracranial stent
US6007573A (en) 1996-09-18 1999-12-28 Microtherapeutics, Inc. Intracranial stent and method of use
WO1998011847A1 (en) 1996-09-20 1998-03-26 Houser Russell A Radially expanding prostheses and systems for their deployment
US5690667A (en) 1996-09-26 1997-11-25 Target Therapeutics Vasoocclusion coil having a polymer tip
US6086610A (en) 1996-10-22 2000-07-11 Nitinol Devices & Components Composite self expanding stent device having a restraining element
US6984240B1 (en) 1996-10-25 2006-01-10 Target Therapeutics, Inc. Detachable multidiameter vasoocclusive coil
US7591846B2 (en) 1996-11-04 2009-09-22 Boston Scientific Scimed, Inc. Methods for deploying stents in bifurcations
AU4896797A (en) 1996-11-04 1998-05-29 Davidson, Charles Extendible stent apparatus and method for deploying the same
US6325826B1 (en) 1998-01-14 2001-12-04 Advanced Stent Technologies, Inc. Extendible stent apparatus
US6599316B2 (en) 1996-11-04 2003-07-29 Advanced Stent Technologies, Inc. Extendible stent apparatus
US6835203B1 (en) 1996-11-04 2004-12-28 Advanced Stent Technologies, Inc. Extendible stent apparatus
EP1230902A1 (en) 1996-11-15 2002-08-14 Advanced Bio Surfaces, Inc. Biomaterial system for in situ tissue repair
US6010529A (en) 1996-12-03 2000-01-04 Atrium Medical Corporation Expandable shielded vessel support
US5776097A (en) 1996-12-19 1998-07-07 University Of California At Los Angeles Method and device for treating intracranial vascular aneurysms
US5733329A (en) 1996-12-30 1998-03-31 Target Therapeutics, Inc. Vaso-occlusive coil with conical end
US5827321A (en) 1997-02-07 1998-10-27 Cornerstone Devices, Inc. Non-Foreshortening intraluminal prosthesis
GB9703859D0 (en) 1997-02-25 1997-04-16 Plante Sylvain Expandable intravascular stent
US6152944A (en) 1997-03-05 2000-11-28 Scimed Life Systems, Inc. Catheter with removable balloon protector and stent delivery system with removable stent protector
US5902475A (en) 1997-04-08 1999-05-11 Interventional Technologies, Inc. Method for manufacturing a stent
US6240616B1 (en) 1997-04-15 2001-06-05 Advanced Cardiovascular Systems, Inc. Method of manufacturing a medicated porous metal prosthesis
WO1998047447A1 (en) 1997-04-23 1998-10-29 Dubrul William R Bifurcated stent and distal protection system
US5836966A (en) 1997-05-22 1998-11-17 Scimed Life Systems, Inc. Variable expansion force stent
FR2764794B1 (en) 1997-06-20 1999-11-12 Nycomed Lab Sa EXPANDED TUBULAR DEVICE WITH VARIABLE THICKNESS
US5951599A (en) 1997-07-09 1999-09-14 Scimed Life Systems, Inc. Occlusion system for endovascular treatment of an aneurysm
US7569066B2 (en) 1997-07-10 2009-08-04 Boston Scientific Scimed, Inc. Methods and devices for the treatment of aneurysms
US5928260A (en) 1997-07-10 1999-07-27 Scimed Life Systems, Inc. Removable occlusion system for aneurysm neck
GB9715241D0 (en) 1997-07-18 1997-09-24 Jeffree Martin A Device for treating aneurysms
US6063070A (en) 1997-08-05 2000-05-16 Target Therapeutics, Inc. Detachable aneurysm neck bridge (II)
US5916235A (en) 1997-08-13 1999-06-29 The Regents Of The University Of California Apparatus and method for the use of detachable coils in vascular aneurysms and body cavities
WO1999011191A1 (en) 1997-08-28 1999-03-11 Boston Scientific Corporation System for implanting a cross-linked polysaccharide fiber and methods of forming and inserting the fiber
US6538026B1 (en) 1997-09-11 2003-03-25 Provasis Therapeutics, Inc. Compositions useful for remodeling body spaces
US6074407A (en) 1997-10-14 2000-06-13 Target Therapeutics, Inc. Delivery catheter for occlusive implants
US6146373A (en) 1997-10-17 2000-11-14 Micro Therapeutics, Inc. Catheter system and method for injection of a liquid embolic composition and a solidification agent
US6511468B1 (en) 1997-10-17 2003-01-28 Micro Therapeutics, Inc. Device and method for controlling injection of liquid embolic composition
WO1999026559A1 (en) 1997-11-25 1999-06-03 Triad Vascular Systems, Inc. Layered endovascular graft
US6159165A (en) 1997-12-05 2000-12-12 Micrus Corporation Three dimensional spherical micro-coils manufactured from radiopaque nickel-titanium microstrand
US5957975A (en) 1997-12-15 1999-09-28 The Cleveland Clinic Foundation Stent having a programmed pattern of in vivo degradation
US6036720A (en) 1997-12-15 2000-03-14 Target Therapeutics, Inc. Sheet metal aneurysm neck bridge
US6190406B1 (en) 1998-01-09 2001-02-20 Nitinal Development Corporation Intravascular stent having tapered struts
US5873907A (en) 1998-01-27 1999-02-23 Endotex Interventional Systems, Inc. Electrolytic stent delivery system and methods of use
WO1999044538A1 (en) 1998-01-27 1999-09-10 The Regents Of The University Of California Biodegradable polymer/protein based coils for intralumenal implants
US20070093889A1 (en) 1999-01-27 2007-04-26 Wu Benjamin M Non-Fragmenting Low Friction Bioactive Absorbable Coils for Brain Aneurysm Therapy
US6395019B2 (en) 1998-02-09 2002-05-28 Trivascular, Inc. Endovascular graft
US6395018B1 (en) 1998-02-09 2002-05-28 Wilfrido R. Castaneda Endovascular graft and process for bridging a defect in a main vessel near one of more branch vessels
US5935145A (en) 1998-02-13 1999-08-10 Target Therapeutics, Inc. Vaso-occlusive device with attached polymeric materials
US5941888A (en) 1998-02-18 1999-08-24 Target Therapeutics, Inc. Vaso-occlusive member assembly with multiple detaching points
US6077260A (en) 1998-02-19 2000-06-20 Target Therapeutics, Inc. Assembly containing an electrolytically severable joint for endovascular embolic devices
US5938697A (en) 1998-03-04 1999-08-17 Scimed Life Systems, Inc. Stent having variable properties
US6179868B1 (en) 1998-03-27 2001-01-30 Janet Burpee Stent with reduced shortening
US6096021A (en) 1998-03-30 2000-08-01 The University Of Virginia Patent Foundation Flow arrest, double balloon technique for occluding aneurysms or blood vessels
US6063111A (en) 1998-03-31 2000-05-16 Cordis Corporation Stent aneurysm treatment system and method
US6015424A (en) 1998-04-28 2000-01-18 Microvention, Inc. Apparatus and method for vascular embolization
US6168615B1 (en) 1998-05-04 2001-01-02 Micrus Corporation Method and apparatus for occlusion and reinforcement of aneurysms
US6497722B1 (en) 1998-05-04 2002-12-24 Jomed Gmbh Methods and apparatus for in-vivo tailored stents indicated for use in tortuous anatomy
US6463317B1 (en) 1998-05-19 2002-10-08 Regents Of The University Of Minnesota Device and method for the endovascular treatment of aneurysms
US6099559A (en) 1998-05-28 2000-08-08 Medtronic Ave, Inc. Endoluminal support assembly with capped ends
US6015433A (en) 1998-05-29 2000-01-18 Micro Therapeutics, Inc. Rolled stent with waveform perforation pattern
WO1999062432A1 (en) 1998-06-04 1999-12-09 New York University Endovascular thin film devices and methods for treating and preventing stroke
US6139564A (en) 1998-06-16 2000-10-31 Target Therapeutics Inc. Minimally occlusive flow disruptor stent for bridging aneurysm necks
US5935148A (en) 1998-06-24 1999-08-10 Target Therapeutics, Inc. Detachable, varying flexibility, aneurysm neck bridge
US6165193A (en) 1998-07-06 2000-12-26 Microvention, Inc. Vascular embolization with an expansible implant
US6136011A (en) 1998-07-14 2000-10-24 Advanced Cardiovascular Systems, Inc. Stent delivery system and method of use
US6096175A (en) 1998-07-17 2000-08-01 Micro Therapeutics, Inc. Thin film stent
US6656218B1 (en) 1998-07-24 2003-12-02 Micrus Corporation Intravascular flow modifier and reinforcement device
US6093199A (en) 1998-08-05 2000-07-25 Endovascular Technologies, Inc. Intra-luminal device for treatment of body cavities and lumens and method of use
US6605294B2 (en) 1998-08-14 2003-08-12 Incept Llc Methods of using in situ hydration of hydrogel articles for sealing or augmentation of tissue or vessels
US6152943A (en) 1998-08-14 2000-11-28 Incept Llc Methods and apparatus for intraluminal deposition of hydrogels
US6818018B1 (en) 1998-08-14 2004-11-16 Incept Llc In situ polymerizable hydrogels
US7410482B2 (en) 1998-09-04 2008-08-12 Boston Scientific-Scimed, Inc. Detachable aneurysm neck bridge
AU5905599A (en) 1998-09-04 2000-03-27 Boston Scientific Limited Detachable aneurysm neck closure patch
US8016852B2 (en) 1998-11-10 2011-09-13 Stryker Corporation Bioactive components for incorporation with vaso-occlusive members
EP1051116B8 (en) 1998-12-01 2009-06-10 Washington University Embolization device
US6558414B2 (en) 1999-02-02 2003-05-06 Impra, Inc. Partial encapsulation of stents using strips and bands
US6398803B1 (en) 1999-02-02 2002-06-04 Impra, Inc., A Subsidiary Of C.R. Bard, Inc. Partial encapsulation of stents
US6231597B1 (en) 1999-02-16 2001-05-15 Mark E. Deem Apparatus and methods for selectively stenting a portion of a vessel wall
US6248122B1 (en) 1999-02-26 2001-06-19 Vascular Architects, Inc. Catheter with controlled release endoluminal prosthesis
US6221066B1 (en) 1999-03-09 2001-04-24 Micrus Corporation Shape memory segmented detachable coil
US6613074B1 (en) 1999-03-10 2003-09-02 Cordis Corporation Endovascular aneurysm embolization device
US6428558B1 (en) 1999-03-10 2002-08-06 Cordis Corporation Aneurysm embolization device
US6273910B1 (en) 1999-03-11 2001-08-14 Advanced Cardiovascular Systems, Inc. Stent with varying strut geometry
EP1173110B1 (en) 1999-04-15 2009-07-08 Smart Therapeutics, Inc. Intravascular stent for treating neurovascular vessel lesion
US6258117B1 (en) 1999-04-15 2001-07-10 Mayo Foundation For Medical Education And Research Multi-section stent
US6899730B1 (en) 1999-04-15 2005-05-31 Scimed Life Systems, Inc. Catheter-stent device
US6273911B1 (en) 1999-04-22 2001-08-14 Advanced Cardiovascular Systems, Inc. Variable strength stent
US6673103B1 (en) 1999-05-20 2004-01-06 Scimed Life Systems, Inc. Mesh and stent for increased flexibility
JP2003500106A (en) 1999-05-21 2003-01-07 マイクロ・セラピューティクス・インコーポレーテッド Method for delivering uniformly dispersed high viscosity embolic compositions in vivo
US20020169473A1 (en) 1999-06-02 2002-11-14 Concentric Medical, Inc. Devices and methods for treating vascular malformations
US6375668B1 (en) 1999-06-02 2002-04-23 Hanson S. Gifford Devices and methods for treating vascular malformations
US6280457B1 (en) 1999-06-04 2001-08-28 Scimed Life Systems, Inc. Polymer covered vaso-occlusive devices and methods of producing such devices
US6569193B1 (en) 1999-07-22 2003-05-27 Advanced Cardiovascular Systems, Inc. Tapered self-expanding stent
US6312421B1 (en) 1999-07-23 2001-11-06 Neurovasx, Inc. Aneurysm embolization material and device
US6309367B1 (en) 1999-07-23 2001-10-30 Neurovasx, Inc. Aneurysm shield
CN1409622A (en) 1999-09-23 2003-04-09 先进扩张技术公司 Bifurcation stent system and method
US6238403B1 (en) 1999-10-04 2001-05-29 Microvention, Inc. Filamentous embolic device with expansible elements
US6602261B2 (en) 1999-10-04 2003-08-05 Microvention, Inc. Filamentous embolic device with expansile elements
US8048104B2 (en) 2000-10-30 2011-11-01 Dendron Gmbh Device for the implantation of occlusion spirals
US6428569B1 (en) 1999-11-09 2002-08-06 Scimed Life Systems Inc. Micro structure stent configurations
US7226475B2 (en) 1999-11-09 2007-06-05 Boston Scientific Scimed, Inc. Stent with variable properties
US6471672B1 (en) 1999-11-10 2002-10-29 Scimed Life Systems Selective high pressure dilation balloon
US6585758B1 (en) 1999-11-16 2003-07-01 Scimed Life Systems, Inc. Multi-section filamentary endoluminal stent
US6537310B1 (en) 1999-11-19 2003-03-25 Advanced Bio Prosthetic Surfaces, Ltd. Endoluminal implantable devices and method of making same
US6331184B1 (en) 1999-12-10 2001-12-18 Scimed Life Systems, Inc. Detachable covering for an implantable medical device
US6350270B1 (en) 2000-01-24 2002-02-26 Scimed Life Systems, Inc. Aneurysm liner
US6312463B1 (en) 2000-02-01 2001-11-06 Endotex Interventional Systems, Inc. Micro-porous mesh stent with hybrid structure
US6346117B1 (en) 2000-03-02 2002-02-12 Prodesco, Inc. Bag for use in the intravascular treatment of saccular aneurysms
US6391037B1 (en) 2000-03-02 2002-05-21 Prodesco, Inc. Bag for use in the intravascular treatment of saccular aneurysms
US6929658B1 (en) 2000-03-09 2005-08-16 Design & Performance-Cyprus Limited Stent with cover connectors
US6632241B1 (en) 2000-03-22 2003-10-14 Endovascular Technologies, Inc. Self-expanding, pseudo-braided intravascular device
US6315708B1 (en) 2000-03-31 2001-11-13 Cordis Corporation Stent with self-expanding end sections
US20030114918A1 (en) 2000-04-28 2003-06-19 Garrison Michi E. Stent graft assembly and method
US6652576B1 (en) 2000-06-07 2003-11-25 Advanced Cardiovascular Systems, Inc. Variable stiffness stent
US7052510B1 (en) 2000-06-14 2006-05-30 Medinol, Ltd. Two Balloon staged stent expansion
US7153323B1 (en) 2000-06-30 2006-12-26 Boston Scientific Scimed, Inc. Aneurysm liner with multi-segment extender
US6855154B2 (en) 2000-08-11 2005-02-15 University Of Louisville Research Foundation, Inc. Endovascular aneurysm treatment device and method
US6969401B1 (en) 2000-08-18 2005-11-29 Marotta Thomas R Endovascular prosthesis
AU2001286731A1 (en) 2000-08-25 2002-03-04 Kensey Nash Corporation Covered stents, systems for deploying covered stents
US8313504B2 (en) 2000-09-18 2012-11-20 Cordis Corporation Foam matrix embolization device
US6723108B1 (en) 2000-09-18 2004-04-20 Cordis Neurovascular, Inc Foam matrix embolization device
US8070792B2 (en) 2000-09-22 2011-12-06 Boston Scientific Scimed, Inc. Stent
US6605101B1 (en) 2000-09-26 2003-08-12 Microvention, Inc. Microcoil vaso-occlusive device with multi-axis secondary configuration
US7033374B2 (en) 2000-09-26 2006-04-25 Microvention, Inc. Microcoil vaso-occlusive device with multi-axis secondary configuration
US7029486B2 (en) 2000-09-26 2006-04-18 Microvention, Inc. Microcoil vaso-occlusive device with multi-axis secondary configuration
JP4817088B2 (en) 2000-10-10 2011-11-16 株式会社林原生物化学研究所 Embolization material
CA2409104A1 (en) 2000-10-11 2002-04-18 Micro Therapeutics, Inc. Methods for treating aneurysms
US7037330B1 (en) 2000-10-16 2006-05-02 Scimed Life Systems, Inc. Neurovascular stent and method
US6814754B2 (en) 2000-10-30 2004-11-09 Secant Medical, Llc Woven tubular graft with regions of varying flexibility
JP4532070B2 (en) 2000-11-17 2010-08-25 エビーシオ・メディカル・デバイセズ・ユーエルシー Endovascular prosthesis
US7306598B2 (en) 2000-11-24 2007-12-11 Dfine, Inc. Polymer matrix devices for treatment of vascular malformations
US6958061B2 (en) 2000-11-24 2005-10-25 Csaba Truckai Microspheres with sacrificial coatings for vaso-occlusive systems
BE1013757A6 (en) 2000-12-12 2002-07-02 Frid Noureddine Luminal endoprosthesis MODULAR.
CA2432033A1 (en) 2000-12-15 2002-06-20 Donald R. Ricci Endovascular prosthesis delivery system
US6547804B2 (en) 2000-12-27 2003-04-15 Scimed Life Systems, Inc. Selectively permeable highly distensible occlusion balloon
US20020082620A1 (en) 2000-12-27 2002-06-27 Elaine Lee Bioactive materials for aneurysm repair
US6603994B2 (en) 2000-12-28 2003-08-05 Scimed Life Systems, Inc. Apparatus and method for internally inducing a magnetic field in an aneurysm to embolize aneurysm with magnetically-controllable substance
US8038708B2 (en) 2001-02-05 2011-10-18 Cook Medical Technologies Llc Implantable device with remodelable material and covering material
AU2002252307B2 (en) 2001-03-13 2007-07-05 Medinol, Ltd. Method and apparatus for stenting
US7294137B2 (en) 2001-03-27 2007-11-13 Boston Scientific Scimed Device for multi-modal treatment of vascular lesions
US6585753B2 (en) 2001-03-28 2003-07-01 Scimed Life Systems, Inc. Expandable coil stent
EP1258230A3 (en) 2001-03-29 2003-12-10 CardioSafe Ltd Balloon catheter device
US6602269B2 (en) 2001-03-30 2003-08-05 Scimed Life Systems Embolic devices capable of in-situ reinforcement
DE10118017B4 (en) 2001-04-10 2017-04-13 Dendron Gmbh Occlusion coil and device for implantation of occlusion coils
US6855153B2 (en) 2001-05-01 2005-02-15 Vahid Saadat Embolic balloon
EP1401338B1 (en) 2001-05-29 2011-07-20 Microvention, Inc. Method of manufacturing expansile filamentous embolization devices
US6692510B2 (en) 2001-06-14 2004-02-17 Cordis Neurovascular, Inc. Aneurysm embolization device and deployment system
US6454780B1 (en) 2001-06-21 2002-09-24 Scimed Life Systems, Inc. Aneurysm neck obstruction device
US20030181927A1 (en) 2001-06-21 2003-09-25 Wallace Michael P. Aneurysm neck obstruction device
US20030100945A1 (en) 2001-11-23 2003-05-29 Mindguard Ltd. Implantable intraluminal device and method of using same in treating aneurysms
US6605056B2 (en) 2001-07-11 2003-08-12 Scimed Life Systems, Inc. Conformable balloon
US20030014075A1 (en) 2001-07-16 2003-01-16 Microvention, Inc. Methods, materials and apparatus for deterring or preventing endoleaks following endovascular graft implanation
CA2452953A1 (en) 2001-07-18 2003-01-30 The Research Foundation Of State University Of New York Stent vascular intervention device and method
US7572288B2 (en) 2001-07-20 2009-08-11 Microvention, Inc. Aneurysm treatment device and method of use
US8715312B2 (en) 2001-07-20 2014-05-06 Microvention, Inc. Aneurysm treatment device and method of use
US8252040B2 (en) 2001-07-20 2012-08-28 Microvention, Inc. Aneurysm treatment device and method of use
US7547321B2 (en) 2001-07-26 2009-06-16 Alveolus Inc. Removable stent and method of using the same
US20030028209A1 (en) 2001-07-31 2003-02-06 Clifford Teoh Expandable body cavity liner device
ES2319621T3 (en) 2001-08-23 2009-05-11 Darrell C. Gumm ROTARY SYSTEM OF IMPLANT OF ENDOVASCULAR PROTESIS FOR ACCSO OF SIDE BRANCH AND PROTECTION.
US20030045923A1 (en) 2001-08-31 2003-03-06 Mehran Bashiri Hybrid balloon expandable/self expanding stent
US6811560B2 (en) 2001-09-20 2004-11-02 Cordis Neurovascular, Inc. Stent aneurysm embolization method and device
US6802851B2 (en) 2001-09-20 2004-10-12 Gordia Neurovascular, Inc. Stent aneurysm embolization method using collapsible member and embolic coils
US6752825B2 (en) 2001-10-02 2004-06-22 Scimed Life Systems, Inc Nested stent apparatus
US20030093111A1 (en) 2001-10-26 2003-05-15 Concentric Medical Device for vaso-occlusion and interventional therapy
JP4429589B2 (en) 2001-11-15 2010-03-10 コーディス・ニューロバスキュラー・インコーポレイテッド Aneurysm embolization device using an occluding member
JP2003190175A (en) 2001-11-15 2003-07-08 Cordis Neurovascular Inc Aneurysm neck cover for sealing aneurysm
US20060292206A1 (en) 2001-11-26 2006-12-28 Kim Steven W Devices and methods for treatment of vascular aneurysms
US7137993B2 (en) 2001-12-03 2006-11-21 Xtent, Inc. Apparatus and methods for delivery of multiple distributed stents
US7892273B2 (en) 2001-12-03 2011-02-22 Xtent, Inc. Custom length stent apparatus
US20030135266A1 (en) 2001-12-03 2003-07-17 Xtent, Inc. Apparatus and methods for delivery of multiple distributed stents
US20040186551A1 (en) 2003-01-17 2004-09-23 Xtent, Inc. Multiple independent nested stent structures and methods for their preparation and deployment
US7294146B2 (en) 2001-12-03 2007-11-13 Xtent, Inc. Apparatus and methods for delivery of variable length stents
WO2003049600A2 (en) * 2001-12-06 2003-06-19 Stx Medical, Inc. Medical device
US7147661B2 (en) 2001-12-20 2006-12-12 Boston Scientific Santa Rosa Corp. Radially expandable stent
CA2468951A1 (en) 2001-12-20 2003-07-03 Trivascular, Inc. Advanced endovascular graft
JP2005514985A (en) 2002-01-14 2005-05-26 マイクロ セラピューティクス, インコーポレイテッド Method for embolizing an aneurysm site using a high viscosity embolic composition
US7695488B2 (en) 2002-03-27 2010-04-13 Boston Scientific Scimed, Inc. Expandable body cavity liner device
US7094369B2 (en) 2002-03-29 2006-08-22 Scimed Life Systems, Inc. Processes for manufacturing polymeric microspheres
US20030195553A1 (en) 2002-04-12 2003-10-16 Scimed Life Systems, Inc. System and method for retaining vaso-occlusive devices within an aneurysm
US7195648B2 (en) 2002-05-16 2007-03-27 Cordis Neurovascular, Inc. Intravascular stent device
US7771387B2 (en) 2002-05-17 2010-08-10 Boston Scientific Scimed, Inc. Liquid embolic composition delivery devices and methods
US7060083B2 (en) 2002-05-20 2006-06-13 Boston Scientific Scimed, Inc. Foldable vaso-occlusive member
US7338511B2 (en) 2002-05-24 2008-03-04 Boston Scientific-Scimed, Inc. Solid embolic material with variable expansion
US7803179B2 (en) 2002-05-30 2010-09-28 Abbott Vascular Solutions Inc. Intravascular stents
US6833003B2 (en) 2002-06-24 2004-12-21 Cordis Neurovascular Expandable stent and delivery system
US20040002752A1 (en) 2002-06-26 2004-01-01 Scimed Life Systems, Inc. Sacrificial anode stent system
US7485122B2 (en) 2002-06-27 2009-02-03 Boston Scientific Scimed, Inc. Integrated anchor coil in stretch-resistant vaso-occlusive coils
CN101919722A (en) 2002-07-31 2010-12-22 微温森公司 The vascular occluding device of three-part coaxial
US20050171572A1 (en) 2002-07-31 2005-08-04 Microvention, Inc. Multi-layer coaxial vaso-occlusive device
US7141063B2 (en) 2002-08-06 2006-11-28 Icon Medical Corp. Stent with micro-latching hinge joints
US7842377B2 (en) 2003-08-08 2010-11-30 Boston Scientific Scimed, Inc. Porous polymeric particle comprising polyvinyl alcohol and having interior to surface porosity-gradient
US7449236B2 (en) 2002-08-09 2008-11-11 Boston Scientific Scimed, Inc. Porous polymeric particle comprising polyvinyl alcohol and having interior to surface porosity-gradient
US20040034386A1 (en) 2002-08-19 2004-02-19 Michael Fulton Aneurysm stent
US20040044391A1 (en) 2002-08-29 2004-03-04 Stephen Porter Device for closure of a vascular defect and method of treating the same
US8075585B2 (en) 2002-08-29 2011-12-13 Stryker Corporation Device and method for treatment of a vascular defect
US20130090721A1 (en) 2010-06-11 2013-04-11 C. R. Bard, Inc. Highly Flexible Stent and Method of Manufacture
US7001422B2 (en) 2002-09-23 2006-02-21 Cordis Neurovascular, Inc Expandable stent and delivery system
EP1549248A4 (en) 2002-09-26 2015-11-25 Advanced Bio Prosthetic Surfac High strength vacuum deposited nitionol alloy films, medical thin film graft materials and method of making same
US7300459B2 (en) 2002-10-17 2007-11-27 Heuser Richard R Stent with covering and differential dilation
US6994721B2 (en) 2002-10-21 2006-02-07 Israel Henry M Stent assembly
US7588825B2 (en) 2002-10-23 2009-09-15 Boston Scientific Scimed, Inc. Embolic compositions
US7481821B2 (en) 2002-11-12 2009-01-27 Thomas J. Fogarty Embolization device and a method of using the same
US20040111112A1 (en) 2002-11-20 2004-06-10 Hoffmann Gerard Von Method and apparatus for retaining embolic material
US6923829B2 (en) 2002-11-25 2005-08-02 Advanced Bio Prosthetic Surfaces, Ltd. Implantable expandable medical devices having regions of differential mechanical properties and methods of making same
US20040115164A1 (en) 2002-12-17 2004-06-17 Pierce Ryan K. Soft filament occlusive device delivery system
US20050165469A1 (en) 2002-12-24 2005-07-28 Michael Hogendijk Vascular prosthesis including torsional stabilizer and methods of use
US7229454B2 (en) 2003-01-07 2007-06-12 Boston Scientific Scimed, Inc. Occlusive cinching devices and methods of use
US20040193246A1 (en) 2003-03-25 2004-09-30 Microvention, Inc. Methods and apparatus for treating aneurysms and other vascular defects
US7182744B2 (en) 2003-04-25 2007-02-27 Medtronic Vascular Method and apparatus for aneurismal treatment
US7438721B2 (en) 2003-04-25 2008-10-21 Medtronic Vascular, Inc. Universal modular stent graft assembly to accommodate flow to collateral branches
US7112216B2 (en) 2003-05-28 2006-09-26 Boston Scientific Scimed, Inc. Stent with tapered flexibility
US7241308B2 (en) 2003-06-09 2007-07-10 Xtent, Inc. Stent deployment systems and methods
US20040260384A1 (en) 2003-06-17 2004-12-23 Medtronic Ave Superelastic coiled stent
US20050015110A1 (en) 2003-07-18 2005-01-20 Fogarty Thomas J. Embolization device and a method of using the same
US7976823B2 (en) 2003-08-29 2011-07-12 Boston Scientific Scimed, Inc. Ferromagnetic particles and methods
US20050209674A1 (en) 2003-09-05 2005-09-22 Kutscher Tuvia D Balloon assembly (V)
US20050119687A1 (en) 2003-09-08 2005-06-02 Dacey Ralph G.Jr. Methods of, and materials for, treating vascular defects with magnetically controllable hydrogels
US7235083B1 (en) 2003-09-10 2007-06-26 Endovascular Technologies, Inc. Methods and devices for aiding in situ assembly of repair devices
CN101094622A (en) 2003-09-18 2007-12-26 先进生物假体表面有限公司 Medical devices having mems functionality and methods of making same
US20050065592A1 (en) 2003-09-23 2005-03-24 Asher Holzer System and method of aneurism monitoring and treatment
US7122052B2 (en) 2003-09-29 2006-10-17 Stout Medical Group Lp Integral support stent graft assembly
US8133256B2 (en) 2003-10-02 2012-03-13 Lawrence Livermore National Security, Llc Shape memory polymer foams for endovascular therapies
US20070135907A1 (en) 2003-10-02 2007-06-14 The Regents Of The University Of California Stent with expandable foam
WO2005034809A1 (en) 2003-10-10 2005-04-21 William A. Cook Australia Pty. Ltd. Stent graft fenestration
WO2005034808A1 (en) 2003-10-10 2005-04-21 William A. Cook Australia Pty. Ltd. Fenestrated stent grafts
US20050090888A1 (en) 2003-10-28 2005-04-28 Hines Richard A. Pleated stent assembly
US20050096725A1 (en) 2003-10-29 2005-05-05 Pomeranz Mark L. Expandable stent having removable slat members
US7232461B2 (en) 2003-10-29 2007-06-19 Cordis Neurovascular, Inc. Neck covering device for an aneurysm
US7901770B2 (en) 2003-11-04 2011-03-08 Boston Scientific Scimed, Inc. Embolic compositions
US9974674B2 (en) 2003-11-08 2018-05-22 Cook Medical Technologies Llc Branch vessel prothesis with positional indicator system and method
US20050133046A1 (en) 2003-12-17 2005-06-23 Becker Timothy A. Compositions and methods for improved occlusion of vascular defects
US7294123B2 (en) 2003-12-17 2007-11-13 Corris Neurovascular, Inc. Activatable bioactive vascular occlusive device and method of use
US7763011B2 (en) 2003-12-22 2010-07-27 Boston Scientific Scimed, Inc. Variable density braid stent
US7326236B2 (en) 2003-12-23 2008-02-05 Xtent, Inc. Devices and methods for controlling and indicating the length of an interventional element
DE102004003265A1 (en) 2004-01-21 2005-08-11 Dendron Gmbh Device for the implantation of electrically isolated occlusion coils
US8012192B2 (en) 2004-02-18 2011-09-06 Boston Scientific Scimed, Inc. Multi-stent delivery system
US7485123B2 (en) 2004-03-01 2009-02-03 Boston Scientific Scimed, Inc. Complex vaso-occlusive coils
US7488332B2 (en) 2004-03-01 2009-02-10 Boston Scientific Scimed, Inc. Vaso-occlusive coils with non-overlapping sections
US7736671B2 (en) 2004-03-02 2010-06-15 Boston Scientific Scimed, Inc. Embolization
US7901447B2 (en) 2004-12-29 2011-03-08 Boston Scientific Scimed, Inc. Medical devices including a metallic film and at least one filament
WO2005087114A1 (en) 2004-03-10 2005-09-22 Philips Intellectual Property & Standards Gmbh Catheter, apparatus and method for therapeutic embolization
US8398670B2 (en) 2004-03-19 2013-03-19 Aga Medical Corporation Multi-layer braided structures for occluding vascular defects and for occluding fluid flow through portions of the vasculature of the body
US9039724B2 (en) 2004-03-19 2015-05-26 Aga Medical Corporation Device for occluding vascular defects
US8313505B2 (en) 2004-03-19 2012-11-20 Aga Medical Corporation Device for occluding vascular defects
US8777974B2 (en) 2004-03-19 2014-07-15 Aga Medical Corporation Multi-layer braided structures for occluding vascular defects
US20050228434A1 (en) 2004-03-19 2005-10-13 Aga Medical Corporation Multi-layer braided structures for occluding vascular defects
US8500751B2 (en) 2004-03-31 2013-08-06 Merlin Md Pte Ltd Medical device
US8048140B2 (en) 2004-03-31 2011-11-01 Cook Medical Technologies Llc Fenestrated intraluminal stent system
US7247159B2 (en) 2004-04-08 2007-07-24 Cordis Neurovascular, Inc. Activatable bioactive vascular occlusive device
US8024036B2 (en) 2007-03-19 2011-09-20 The Invention Science Fund I, Llc Lumen-traveling biological interface device and method of use
US8512219B2 (en) 2004-04-19 2013-08-20 The Invention Science Fund I, Llc Bioelectromagnetic interface system
US8412348B2 (en) 2004-05-06 2013-04-02 Boston Scientific Neuromodulation Corporation Intravascular self-anchoring integrated tubular electrode body
US7758892B1 (en) 2004-05-20 2010-07-20 Boston Scientific Scimed, Inc. Medical devices having multiple layers
ES2357243T3 (en) 2004-05-21 2011-04-20 Micro Therapeutics, Inc. METAL SPIRALS INTERLATED WITH POLYMERS OR BIOLOGICAL OR BIODEGRADABLE OR SYNTHETIC FIBERS FOR THE EMBOLIZATION OF A BODY CAVITY.
US8267985B2 (en) 2005-05-25 2012-09-18 Tyco Healthcare Group Lp System and method for delivering and deploying an occluding device within a vessel
JP2008502378A (en) 2004-05-25 2008-01-31 チェストナット メディカル テクノロジーズ インコーポレイテッド Flexible vascular closure device
US8628564B2 (en) 2004-05-25 2014-01-14 Covidien Lp Methods and apparatus for luminal stenting
US20060206200A1 (en) 2004-05-25 2006-09-14 Chestnut Medical Technologies, Inc. Flexible vascular occluding device
US8617234B2 (en) 2004-05-25 2013-12-31 Covidien Lp Flexible vascular occluding device
US20050267510A1 (en) 2004-05-26 2005-12-01 Nasser Razack Device for the endovascular treatment of intracranial aneurysms
US7311861B2 (en) 2004-06-01 2007-12-25 Boston Scientific Scimed, Inc. Embolization
US20050277978A1 (en) 2004-06-09 2005-12-15 Secant Medical, Llc Three-dimensional coils for treatment of vascular aneurysms
WO2005122962A1 (en) 2004-06-15 2005-12-29 Cook Incorporated Stent graft with internal tube
US7749242B2 (en) 2004-06-21 2010-07-06 Boston Scientific Scimed, Inc. Expanding vaso-occlusive device
US20050283220A1 (en) 2004-06-22 2005-12-22 Gobran Riad H Blood flow diverters for the treatment of intracranial aneurysms
US7744641B2 (en) 2004-07-21 2010-06-29 Boston Scientific Scimed, Inc. Expandable framework with overlapping connectors
US7651525B2 (en) 2004-08-05 2010-01-26 Medtronic Vascular, Inc. Intraluminal stent assembly and method of deploying the same
US20060079923A1 (en) 2004-08-09 2006-04-13 Manik Chhabra Aneurysm treatment using semi-compliant balloon
US9051411B2 (en) 2004-08-16 2015-06-09 Lawrence Livermore National Security, Llc Shape memory polymers
US20060036045A1 (en) 2004-08-16 2006-02-16 The Regents Of The University Of California Shape memory polymers
EP1827250B1 (en) 2004-08-31 2018-05-16 Cook Medical Technologies LLC Device for treating an aneurysm
EP1788956B1 (en) 2004-09-17 2011-11-09 Codman & Shurtleff, Inc. Vascular occlusion device with an embolic mesh ribbon
US20080004653A1 (en) 2004-09-17 2008-01-03 Sherman Darren R Thin Film Devices for Occlusion of a Vessel
WO2006034153A2 (en) 2004-09-17 2006-03-30 Cordis Neurovascular, Inc. Thin film metallic devices for plugging aneurysms or vessels
EP1788978B1 (en) 2004-09-17 2011-11-09 Codman & Shurtleff, Inc. Thin film devices for temporary or permanent occlusion of a vessel
ATE448737T1 (en) 2004-09-22 2009-12-15 Dendron Gmbh DEVICE FOR IMPLANTING MICROWL COILS
US8226706B2 (en) 2004-09-22 2012-07-24 Cook Medical Technologies Llc Stent graft with integral side arm
US7879064B2 (en) 2004-09-22 2011-02-01 Micro Therapeutics, Inc. Medical implant
EP1799126B1 (en) 2004-10-15 2011-12-07 Codman & Shurtleff, Inc. Remodeling device for aneurysms
CA2622893A1 (en) 2004-10-26 2006-05-04 Medical College Of Georgia Research Institute Devices and methods for aneurysm treatment
WO2006047748A2 (en) 2004-10-26 2006-05-04 Cordis Neurovascular, Inc. Method of delivering embolic particles to an aneurysm
US7147659B2 (en) 2004-10-28 2006-12-12 Cordis Neurovascular, Inc. Expandable stent having a dissolvable portion
US7156871B2 (en) 2004-10-28 2007-01-02 Cordis Neurovascular, Inc. Expandable stent having a stabilized portion
US8388677B2 (en) 2004-10-29 2013-03-05 Boston Scientific Scimed, Inc. Anti-thrombogenic and anti-restenotic vascular medical devices
US8308794B2 (en) 2004-11-15 2012-11-13 IZEK Technologies, Inc. Instrumented implantable stents, vascular grafts and other medical devices
US8771294B2 (en) 2004-11-26 2014-07-08 Biomerix Corporation Aneurysm treatment devices and methods
US20090297582A1 (en) 2004-11-26 2009-12-03 Biomerix Corporation Vascular occlusion devices and methods
US20060116713A1 (en) 2004-11-26 2006-06-01 Ivan Sepetka Aneurysm treatment devices and methods
US20060116709A1 (en) 2004-11-26 2006-06-01 Ivan Sepetka Aneurysm treatment devices and methods
US8292944B2 (en) 2004-12-17 2012-10-23 Reva Medical, Inc. Slide-and-lock stent
US20060136033A1 (en) 2004-12-20 2006-06-22 Vascular Architects, Inc. Coiled stent delivery system and method
US7722529B2 (en) 2004-12-28 2010-05-25 Palo Alto Investors Expandable vessel harness for treating vessel aneurysms
US7857843B2 (en) 2004-12-31 2010-12-28 Boston Scientific Scimed, Inc. Differentially expanded vascular graft
US20060155367A1 (en) * 2005-01-07 2006-07-13 Hines Richard A Micro-pleated stent assembly
US20060155323A1 (en) 2005-01-07 2006-07-13 Porter Stephen C Intra-aneurysm devices
US8287583B2 (en) 2005-01-10 2012-10-16 Taheri Laduca Llc Apparatus and method for deploying an implantable device within the body
US20110054511A1 (en) 2005-01-26 2011-03-03 Micrus Endovascular Corporation Adding microscopic porosity to the surface of a microcoil to be used for medical implantation
MX2007008923A (en) 2005-01-26 2008-02-21 Micrus Endovascular Corp Implantable microcoil with microscopic porosity surface.
US20060178696A1 (en) 2005-02-04 2006-08-10 Porter Stephen C Macroporous materials for use in aneurysms
US7344544B2 (en) 2005-03-28 2008-03-18 Cardica, Inc. Vascular closure system
JP5523700B2 (en) 2005-04-04 2014-06-18 フレキシブル ステンティング ソリューションズ,インク. Flexible stent
DE102005019782A1 (en) 2005-04-28 2006-11-09 Dendron Gmbh Device for implantation of occlusion coils with internal securing means
US8273101B2 (en) 2005-05-25 2012-09-25 Tyco Healthcare Group Lp System and method for delivering and deploying an occluding device within a vessel
AU2005332044B2 (en) 2005-05-25 2012-01-19 Covidien Lp System and method for delivering and deploying and occluding device within a vessel
US8002789B2 (en) 2005-05-31 2011-08-23 Stryker Corporation Stretch-resistant vaso-occlusive devices with flexible detachment junctions
US7708755B2 (en) 2005-06-02 2010-05-04 Codman & Shurtleff Inc. Stretch resistant embolic coil delivery system with combined mechanical and pressure release mechanism
US7819891B2 (en) 2005-06-02 2010-10-26 Codman & Shurtleff, Inc. Stretch resistant embolic coil delivery system with spring release mechanism
US7819892B2 (en) 2005-06-02 2010-10-26 Codman & Shurtleff, Inc. Embolic coil delivery system with spring wire release mechanism
US7799052B2 (en) 2005-06-02 2010-09-21 Codman & Shurtleff, Inc. Stretch resistant embolic coil delivery system with mechanical release mechanism
US7985238B2 (en) 2005-06-02 2011-07-26 Codman & Shurtleff, Inc. Embolic coil delivery system with spring wire release mechanism
US7708754B2 (en) 2005-06-02 2010-05-04 Codman & Shurtleff, Pc Stretch resistant embolic coil delivery system with mechanical release mechanism
US7811305B2 (en) 2005-06-02 2010-10-12 Codman & Shurtleff, Inc. Stretch resistant embolic coil delivery system with spring release mechanism
AU2006269419A1 (en) 2005-07-07 2007-01-18 Nellix, Inc. Systems and methods for endovascular aneurysm treatment
US20070021816A1 (en) 2005-07-21 2007-01-25 The Research Foundation Of State University Of New York Stent vascular intervention device and methods for treating aneurysms
US7850810B2 (en) 2005-07-29 2010-12-14 Gore Enterprise Holdings, Inc. Method of making porous self-cohered web materials
US20070027551A1 (en) 2005-07-29 2007-02-01 Farnsworth Ted R Composite self-cohered web materials
US7604668B2 (en) 2005-07-29 2009-10-20 Gore Enterprise Holdings, Inc. Composite self-cohered web materials
US7914574B2 (en) 2005-08-02 2011-03-29 Reva Medical, Inc. Axially nested slide and lock expandable device
AU2006280948B2 (en) 2005-08-18 2011-10-27 Cook Incorporated Assembly of stent grafts
US8038706B2 (en) 2005-09-08 2011-10-18 Boston Scientific Scimed, Inc. Crown stent assembly
US20070060994A1 (en) 2005-09-12 2007-03-15 Gobran Riad H Blood flow diverters for the treatment of intracranial aneurysms
US8057495B2 (en) 2005-09-13 2011-11-15 Cook Medical Technologies Llc Aneurysm occlusion device
US8956400B2 (en) 2005-10-14 2015-02-17 Flexible Stenting Solutions, Inc. Helical stent
US8545530B2 (en) 2005-10-19 2013-10-01 Pulsar Vascular, Inc. Implantable aneurysm closure systems and methods
WO2007051179A2 (en) 2005-10-27 2007-05-03 Nfocus Neuromedical Inc. Partially covered stent devices and methods of use
US7776079B2 (en) 2005-10-31 2010-08-17 Boston Scientific Scimed, Inc. Conical balloon for deployment into side branch
US7404823B2 (en) 2005-10-31 2008-07-29 Boston Scientific Scimed, Inc. Stent configurations
WO2007055654A1 (en) 2005-11-09 2007-05-18 Merlin Md Pte Ltd Medical device with non-circumferential surface portion
WO2007076179A2 (en) 2005-11-17 2007-07-05 Microvention, Inc. Three-dimensional complex coil
US7540881B2 (en) 2005-12-22 2009-06-02 Boston Scientific Scimed, Inc. Bifurcation stent pattern
US20070150041A1 (en) 2005-12-22 2007-06-28 Nellix, Inc. Methods and systems for aneurysm treatment using filling structures
US7744652B2 (en) 2006-01-23 2010-06-29 Hesham Morsi Aneurysm sealing device
WO2007090127A2 (en) 2006-01-30 2007-08-09 Surgica Corporation Compressible intravascular embolization particles and related methods and delivery systems
US7691124B2 (en) 2006-01-31 2010-04-06 Codman & Shurtleff, Inc. Delivery of therapeutic devices
WO2007088549A2 (en) 2006-02-03 2007-08-09 Design & Performance - Cyprus Limited Implantable graft assembly and aneurysm treatment
US8784477B2 (en) 2011-01-05 2014-07-22 Abbott Cardiovascular Systems Inc. Stent graft with two layer ePTFE layer system with high plasticity and high rigidity
US8585753B2 (en) 2006-03-04 2013-11-19 John James Scanlon Fibrillated biodegradable prosthesis
EP2004270B1 (en) 2006-03-14 2016-11-02 Thermopeutix Inc. Aneurysm coil delivery system
US20070219610A1 (en) 2006-03-20 2007-09-20 Israel Henry M Stent with flap
US20090318941A1 (en) 2006-03-24 2009-12-24 Biomerix Corporation Self-Expandable Endovascular Device For Aneurysm Occlusion
US7766933B2 (en) 2006-03-31 2010-08-03 Codman & Shurtleff, Inc. Stretch resistant design for embolic coils with stabilization bead
US9615832B2 (en) 2006-04-07 2017-04-11 Penumbra, Inc. Aneurysm occlusion system and method
JP5061181B2 (en) 2006-04-07 2012-10-31 ピナンブラ、インク System and method for occluding an aneurysm
CN101500623B (en) 2006-06-15 2016-08-24 微温森公司 A kind of embolization device being made up of expandable polymer
US8478437B2 (en) 2006-06-16 2013-07-02 The Invention Science Fund I, Llc Methods and systems for making a blood vessel sleeve
US8095382B2 (en) 2006-06-16 2012-01-10 The Invention Science Fund I, Llc Methods and systems for specifying a blood vessel sleeve
US7818084B2 (en) 2006-06-16 2010-10-19 The Invention Science Fund, I, LLC Methods and systems for making a blood vessel sleeve
US8163003B2 (en) 2006-06-16 2012-04-24 The Invention Science Fund I, Llc Active blood vessel sleeve methods and systems
US8550344B2 (en) 2006-06-16 2013-10-08 The Invention Science Fund I, Llc Specialty stents with flow control features or the like
US8147537B2 (en) 2006-06-16 2012-04-03 The Invention Science Fund I, Llc Rapid-prototyped custom-fitted blood vessel sleeve
US8551155B2 (en) 2006-06-16 2013-10-08 The Invention Science Fund I, Llc Stent customization system and method
US20070299461A1 (en) 2006-06-21 2007-12-27 Boston Scientific Scimed, Inc. Embolic coils and related components, systems, and methods
US20080004692A1 (en) 2006-06-28 2008-01-03 Henson Michael R Dynamically adjustable vascular stent
WO2008013803A2 (en) 2006-07-24 2008-01-31 Massachusetts Institute Of Technology Endovascular devices with axial perturbations
US20080033341A1 (en) 2006-08-04 2008-02-07 Bay Holdings Ltd. Methods and devices for reducing or blocking blood flow to a selected blood vessel or part thereof
US8460240B2 (en) 2006-08-07 2013-06-11 W. L. Gore & Associates, Inc. Inflatable toroidal-shaped balloons
AU2007285800A1 (en) 2006-08-17 2008-02-21 Nfocus Neuromedical, Inc. Isolation devices for the treatment of aneurysms
EP2056745A2 (en) 2006-08-17 2009-05-13 Nfocus Neuromedical Inc. Aneurysm covering devices and delivery devices
US8034073B2 (en) 2006-08-18 2011-10-11 Codman & Shurtleff, Inc. Stretch resistant embolic coil
US8414637B2 (en) 2006-09-08 2013-04-09 Boston Scientific Scimed, Inc. Stent
WO2008034047A2 (en) 2006-09-15 2008-03-20 Boston Scientific Limited Endoprosthesis with adjustable surface features
US7927348B2 (en) 2006-10-10 2011-04-19 Codman & Shurtleff, Inc. Stretch resistant coil device
US8257431B2 (en) 2006-11-01 2012-09-04 Boston Scientific Scimed, Inc. Multi-furcated ePTFE grafts and stent-graft prostheses and methods of making the same
JP2010508910A (en) 2006-11-02 2010-03-25 アール. ショーン パクバズ, Devices and methods for accessing and treating aneurysms
WO2008063455A1 (en) 2006-11-13 2008-05-29 Hines Richard A Over-the wire exclusion device and system for delivery
US8795346B2 (en) 2006-11-20 2014-08-05 Boston Scientific Scimed, Inc. Semi rigid edge protection design for stent delivery system
US8187315B1 (en) 2006-12-08 2012-05-29 Cardica, Inc. Partial stent for treatment of a vascular aneurysm
WO2008074027A1 (en) 2006-12-13 2008-06-19 Biomerix Corporation Aneurysm occlusion devices
US8473030B2 (en) 2007-01-12 2013-06-25 Medtronic Vascular, Inc. Vessel position and configuration imaging apparatus and methods
US20080177376A1 (en) 2007-01-18 2008-07-24 Medtronic Vascular, Inc. Stent With Improved Flexibility and Method for Making Same
EP4005537A1 (en) 2007-02-12 2022-06-01 C.R. Bard Inc. Highly flexible stent and method of manufacture
US8333799B2 (en) 2007-02-12 2012-12-18 C. R. Bard, Inc. Highly flexible stent and method of manufacture
DE102007012964A1 (en) 2007-03-06 2008-09-11 Phenox Gmbh Implant for influencing blood flow
US8348994B2 (en) 2007-03-09 2013-01-08 Novostent Corporation Vascular prosthesis with alternating helical sections
KR20100015520A (en) 2007-03-13 2010-02-12 마이크로 테라퓨틱스 인코포레이티드 An implant including a coil and a stretch-resistant member
US20080249608A1 (en) 2007-04-04 2008-10-09 Vipul Dave Bioabsorbable Polymer, Bioabsorbable Composite Stents
US8715336B2 (en) 2007-04-19 2014-05-06 Medtronic Vascular, Inc. Methods and apparatus for treatment of aneurysms adjacent to branch arteries
US8425541B2 (en) 2007-04-27 2013-04-23 Wisconsin Alumni Research Foundation Aneurysm occlusion device containing bioactive and biocompatible copolymer shell and a liquid embolic agent
US20110022149A1 (en) 2007-06-04 2011-01-27 Cox Brian J Methods and devices for treatment of vascular defects
EP2171143B1 (en) 2007-06-20 2015-10-21 Atex Technologies, Inc. Compressible resilient fabric, devices, and methods
US20080319533A1 (en) 2007-06-22 2008-12-25 Neurovasx, Inc. Aneurysm occlusion assist device
WO2009003049A2 (en) 2007-06-25 2008-12-31 Micro Vention, Inc. Self-expanding prosthesis
US8048147B2 (en) 2007-06-27 2011-11-01 Aga Medical Corporation Branched stent/graft and method of fabrication
DE102007031796A1 (en) 2007-07-07 2009-01-08 WRW Consulting GbR (Vertretungsberechtigter Gesellschafter: Dr. Walter Reith, 66424 Homburg) Radially expandable system for use in body tubes
US9814611B2 (en) 2007-07-31 2017-11-14 Edwards Lifesciences Cardiaq Llc Actively controllable stent, stent graft, heart valve and method of controlling same
WO2009020653A1 (en) 2007-08-08 2009-02-12 Cleveland Clinic Foundation Branched stent graft system
US8597342B2 (en) 2007-08-24 2013-12-03 Cook Medical Technologies Llc Textile graft for in situ fenestration
WO2009036219A1 (en) 2007-09-11 2009-03-19 Nfocus Neuromedical Inc. Aneurysm cover device for embolic delivery and retention
US8663309B2 (en) 2007-09-26 2014-03-04 Trivascular, Inc. Asymmetric stent apparatus and method
US8926680B2 (en) 2007-11-12 2015-01-06 Covidien Lp Aneurysm neck bridging processes with revascularization systems methods and products thereby
WO2009052432A2 (en) 2007-10-19 2009-04-23 Coherex Medical, Inc. Medical device for modification of left atrial appendange and related systems and methods
WO2009061969A2 (en) 2007-11-06 2009-05-14 Daniel Gelbart In vivo inflatable structures, for example to expand stents
WO2009062264A1 (en) 2007-11-15 2009-05-22 Endogad Research Pty Limited Hybrid intraluminal device
US7988721B2 (en) 2007-11-30 2011-08-02 Reva Medical, Inc. Axially-radially nested expandable device
ES2372257T3 (en) 2007-12-14 2012-01-17 Micrus Endovascular Llc MULTIFILAMENT SPIRAL FOR INTERVENTIONAL THERAPIES.
EP2266639B1 (en) 2007-12-21 2016-10-05 MicroVention, Inc. Methods for preparing hydrogel filaments for biomedical use
WO2009086269A2 (en) 2007-12-21 2009-07-09 Massachusetts Institute Of Technology Endovascular devices/catheter platforms and methods for achieving congruency in sequentially deployed devices
US8574284B2 (en) 2007-12-26 2013-11-05 Cook Medical Technologies Llc Low profile non-symmetrical bare alignment stents with graft
US9180030B2 (en) 2007-12-26 2015-11-10 Cook Medical Technologies Llc Low profile non-symmetrical stent
US8728145B2 (en) 2008-12-11 2014-05-20 Cook Medical Technologies Llc Low profile non-symmetrical stents and stent-grafts
US8992593B2 (en) 2007-12-26 2015-03-31 Cook Medical Technologies Llc Apparatus and methods for deployment of a modular stent-graft system
US8246672B2 (en) 2007-12-27 2012-08-21 Cook Medical Technologies Llc Endovascular graft with separately positionable and removable frame units
US7963987B2 (en) 2007-12-28 2011-06-21 Cook Medical Technologies Llc Sequential implant delivery system
US8623071B2 (en) 2008-01-07 2014-01-07 DePuy Synthes Products, LLC Radiopaque super-elastic intravascular stent
US20110046716A1 (en) 2008-02-20 2011-02-24 Murray Vascular Pty Limited Stent
US20090227976A1 (en) 2008-03-05 2009-09-10 Calabria Marie F Multiple biocompatible polymeric strand aneurysm embolization system and method
US20090228029A1 (en) 2008-03-05 2009-09-10 Neuro Vasx, Inc. Aneurysm shield anchoring device
EP2262443A2 (en) 2008-03-10 2010-12-22 NFocus Neuromedical, Inc. Stents and stent grafts
US8100960B2 (en) 2008-03-20 2012-01-24 Medtronic Vascular, Inc. Bloused stent-graft and fenestration method
US8974518B2 (en) 2008-03-25 2015-03-10 Medtronic Vascular, Inc. Eversible branch stent-graft and deployment method
US8257684B2 (en) 2008-03-26 2012-09-04 Neurosigma, Inc. Methods for identifying and targeting autonomic brain regions
EP2633823B1 (en) 2008-04-21 2016-06-01 Covidien LP Braid-ball embolic devices and delivery systems
WO2009132141A1 (en) 2008-04-22 2009-10-29 Coherex Medical, Inc. Device, system and method for aneurysm embolization
CN102083493A (en) 2008-05-01 2011-06-01 安纽克罗斯有限责任公司 Aneurysm occlusion device
CN106974691A (en) 2008-05-02 2017-07-25 斯昆特医疗公司 Thread device for treating vascular defects
US9675482B2 (en) 2008-05-13 2017-06-13 Covidien Lp Braid implant delivery systems
US20090299448A1 (en) 2008-05-30 2009-12-03 Neurovasx, Inc. Aneurysm treatment system
AU2009256084A1 (en) 2008-06-04 2009-12-10 Nellix, Inc. Sealing apparatus and methods of use
US20100016833A1 (en) 2008-07-15 2010-01-21 Ogle Matthew F Devices for the Treatment of Vascular Aneurysm
DE202008009604U1 (en) 2008-07-17 2008-11-27 Sahl, Harald, Dr. Membrane implant for the treatment of cerebral artery aneurysms
CA2731735A1 (en) 2008-07-22 2010-01-28 Microtherapeutics, Inc. Vascular remodeling device
WO2010016923A1 (en) 2008-08-06 2010-02-11 Boston Scientific Scimed, Inc. Vaso-occlusive devices with textured surfaces
US8353943B2 (en) 2008-08-29 2013-01-15 Cook Medical Technologies Llc Variable weave graft with metal strand reinforcement for in situ fenestration
US8388650B2 (en) 2008-09-05 2013-03-05 Pulsar Vascular, Inc. Systems and methods for supporting or occluding a physiological opening or cavity
US20100069948A1 (en) 2008-09-12 2010-03-18 Micrus Endovascular Corporation Self-expandable aneurysm filling device, system and method of placement
US8795347B2 (en) 2008-09-25 2014-08-05 Advanced Bifurcation Systems, Inc. Methods and systems for treating a bifurcation with provisional side branch stenting
US8769796B2 (en) 2008-09-25 2014-07-08 Advanced Bifurcation Systems, Inc. Selective stent crimping
CA2737753C (en) 2008-10-10 2017-03-14 Reva Medical, Inc. Expandable slide and lock stent
US8202292B2 (en) 2008-10-13 2012-06-19 Stryker Corporation Vaso-occlusive coil delivery system
US8470013B2 (en) 2008-10-20 2013-06-25 Imds Corporation Systems and methods for aneurysm treatment and vessel occlusion
US20100131002A1 (en) 2008-11-24 2010-05-27 Connor Robert A Stent with a net layer to embolize and aneurysm
US8734502B2 (en) 2008-12-17 2014-05-27 Cook Medical Technologies Llc Tapered stent and flexible prosthesis
EP2394610A1 (en) 2009-02-06 2011-12-14 Keio University Stent to be used in tubular organ in vivo
WO2010102254A2 (en) 2009-03-06 2010-09-10 The Regents Of The University Of California Thin film vascular stent and biocompatible surface treatment
GB2469073A (en) 2009-03-31 2010-10-06 Barking Havering And Redbridge Balloon Assisted Occlusion of Aneurysms
US20100268320A1 (en) 2009-04-17 2010-10-21 Medtronic Vascular, Inc. Endovascular Implant Having an Integral Graft Component and Method of Manufacture
WO2010123003A1 (en) 2009-04-20 2010-10-28 株式会社カネカ Embolization coil
US20100274276A1 (en) 2009-04-22 2010-10-28 Ricky Chow Aneurysm treatment system, device and method
WO2010134914A1 (en) 2009-05-20 2010-11-25 University Of Miami Spherical helix embolic coils for the treatment of cerebral aneurysms
US8409269B2 (en) 2009-12-21 2013-04-02 Covidien Lp Procedures for vascular occlusion
US20110004294A1 (en) 2009-07-02 2011-01-06 Abbott Laboratories Fatigue-resistant stent
US8357179B2 (en) 2009-07-08 2013-01-22 Concentric Medical, Inc. Vascular and bodily duct treatment devices and methods
US8795345B2 (en) 2009-07-08 2014-08-05 Concentric Medical, Inc. Vascular and bodily duct treatment devices and methods
US8529596B2 (en) 2009-07-08 2013-09-10 Concentric Medical, Inc. Vascular and bodily duct treatment devices and methods
US20110009941A1 (en) 2009-07-08 2011-01-13 Concentric Medical, Inc. Vascular and bodily duct treatment devices and methods
US8357178B2 (en) 2009-07-08 2013-01-22 Concentric Medical, Inc. Vascular and bodily duct treatment devices and methods
US8491646B2 (en) 2009-07-15 2013-07-23 Endologix, Inc. Stent graft
WO2011017123A2 (en) 2009-07-27 2011-02-10 Endologix, Inc. Stent graft
US10420862B2 (en) 2009-08-24 2019-09-24 Aresenal AAA, LLC. In-situ forming foams for treatment of aneurysms
US20110054589A1 (en) 2009-08-27 2011-03-03 Boston Scientific Scimed, Inc. Stent with variable cross section braiding filament and method for making same
KR101788338B1 (en) 2009-09-04 2017-10-19 펄사 배스큘라, 아이엔씨. Systems and methods for enclosing an anatomical opening
US9474532B2 (en) 2009-09-09 2016-10-25 Kaneka Corporation Embolization coil
ES2445164T3 (en) 2009-10-06 2014-02-28 Regents Of The University Of Minnesota Bioreabsorbable embolization microspheres
KR20110043799A (en) 2009-10-16 2011-04-28 강호창 Micro-coil assembly
KR101745748B1 (en) 2009-10-26 2017-06-12 마이크로벤션, 인코포레이티드 Embolization device constructed from expansile polymer
US9649211B2 (en) 2009-11-04 2017-05-16 Confluent Medical Technologies, Inc. Alternating circumferential bridge stent design and methods for use thereof
US20110152993A1 (en) 2009-11-05 2011-06-23 Sequent Medical Inc. Multiple layer filamentary devices or treatment of vascular defects
AU2010314994B2 (en) 2009-11-09 2016-10-06 Spotlight Technology Partners Llc Fragmented hydrogels
US20110202085A1 (en) 2009-11-09 2011-08-18 Siddharth Loganathan Braid Ball Embolic Device Features
WO2011057131A1 (en) 2009-11-09 2011-05-12 Spotlight Technology Partners Llc Polysaccharide based hydrogels
AU2010339980C1 (en) 2009-12-16 2014-07-10 Endoshape, Inc. Multi-fiber shape memory device
DE102009060228B4 (en) 2009-12-23 2014-12-04 Acandis Gmbh & Co. Kg Medical devices
US8906057B2 (en) 2010-01-04 2014-12-09 Aneuclose Llc Aneurysm embolization by rotational accumulation of mass
US20110184454A1 (en) 2010-01-27 2011-07-28 Penumbra, Inc. Embolic implants
EP2351779B1 (en) 2010-01-27 2019-04-24 Biosphere Medical, Inc. Microspheres and method of making the microspheres
EP2528541B1 (en) 2010-01-28 2016-05-18 Covidien LP Vascular remodeling device
US9468442B2 (en) 2010-01-28 2016-10-18 Covidien Lp Vascular remodeling device
CN102933161A (en) 2010-02-08 2013-02-13 萨帕斯医药有限公司 Method and device for treating cerebrovascular pathologies and delivery system therefor
KR101250443B1 (en) 2010-02-08 2013-04-08 권오기 Embolus forming in-vivo indwelling-coil and the makigng methods for Embolus forming in-vivo indwelling coil
CN102188300B (en) 2010-03-02 2014-05-28 上海微创医疗器械(集团)有限公司 Aneurismal surgical device
EP2365009A1 (en) 2010-03-10 2011-09-14 Universite Claude Bernard Lyon 1 (UCBL) Radiopaque, non-biodegradable, water-insoluble iodinated benzyl ethers of poly(vinyl alcohol), preparation method thereof, injectable embolizing compositions containing thereof and use thereof
WO2011119883A1 (en) 2010-03-24 2011-09-29 Advanced Bifurcation Systems, Inc. Stent alignment during treatment of a bifurcation
US20120078285A1 (en) 2010-04-01 2012-03-29 Penumbra, Inc. Balloon catheter for intravascular therapies
AU2010201676B1 (en) 2010-04-23 2010-07-22 Cook Medical Technologies Llc Curve forming stent graft
US8702776B2 (en) 2010-04-26 2014-04-22 Paul Heltai Method for deploying a sleeve and tubing device for restricting and constricting aneurysms and a sleeve and tubing device and system
US20110276071A1 (en) 2010-05-08 2011-11-10 Connor Robert A Vasospasm-reducing aneurysm clip
US8840867B2 (en) 2010-05-20 2014-09-23 Val-Chum Limited Partnership Embolizing sclerosing hydrogel
EP2387951B1 (en) 2010-05-23 2012-12-26 Occlutech Holding AG Braided medical device and manufacturing method therefore
JP5801037B2 (en) 2010-05-25 2015-10-28 アクセスポイント テクノロジーズ有限会社 Stent
WO2011150118A2 (en) 2010-05-25 2011-12-01 The Regents Of The University Of California Ultra-low fractional area coverage flow diverter for treating aneurysms and vascular diseases
US9220506B2 (en) 2010-06-16 2015-12-29 DePuy Synthes Products, Inc. Occlusive device with stretch resistant member and anchor filament
AU2010202544B1 (en) 2010-06-18 2010-08-26 Cook Incorporated Side branch stent graft
US8425548B2 (en) 2010-07-01 2013-04-23 Aneaclose LLC Occluding member expansion and then stent expansion for aneurysm treatment
US10265200B2 (en) 2010-08-10 2019-04-23 Cook Medical Technologies Llc Medical prostheses having bundled and non-bundled regions
DE102010044746A1 (en) 2010-09-08 2012-03-08 Phenox Gmbh Implant for influencing the blood flow in arteriovenous malformations
US8998947B2 (en) 2010-09-10 2015-04-07 Medina Medical, Inc. Devices and methods for the treatment of vascular defects
US20130066357A1 (en) 2010-09-10 2013-03-14 Maria Aboytes Devices and methods for the treatment of vascular defects
EP3354210B1 (en) 2010-09-10 2022-10-26 Covidien LP Devices for the treatment of vascular defects
US9186149B2 (en) 2010-10-12 2015-11-17 Boston Scientific Scimed, Inc. Vaso-occlusive device
WO2012078678A1 (en) 2010-12-06 2012-06-14 Tyco Healthcare Group Lp Vascular remodeling device
US9867725B2 (en) 2010-12-13 2018-01-16 Microvention, Inc. Stent
JP2014507196A (en) 2010-12-28 2014-03-27 ボストン サイエンティフィック サイムド,インコーポレイテッド Stent
JP2014508559A (en) 2010-12-30 2014-04-10 ボストン サイエンティフィック サイムド,インコーポレイテッド Multi-stage open stent design
US8535590B2 (en) 2011-01-12 2013-09-17 Cook Medical Technologies Llc Spray system and method of making phase separated polymer membrane structures
US10166128B2 (en) 2011-01-14 2019-01-01 W. L. Gore & Associates. Inc. Lattice
US9839540B2 (en) 2011-01-14 2017-12-12 W. L. Gore & Associates, Inc. Stent
CA2824284C (en) 2011-01-17 2020-10-27 Novita Therapeutics, Llc Ballstent device and methods of use
US9095420B2 (en) 2011-01-24 2015-08-04 Tufts Medical Center, Inc. Endovascular stent
CA2826615A1 (en) 2011-02-04 2012-08-09 Concentric Medical, Inc. Vascular and bodily duct treatment devices and methods
EP2672932B1 (en) 2011-02-08 2018-09-19 Advanced Bifurcation Systems, Inc. System for treating a bifurcation with a fully crimped stent
US20130041454A1 (en) 2011-02-09 2013-02-14 Business Expectations Llc Sensor Actuated Stent
CN203591290U (en) 2011-02-11 2014-05-14 斯瑞克公司 Vascular occlusion device
CN103442653B (en) 2011-02-11 2016-06-01 柯惠有限合伙公司 Two benches launches aneurysma embolization device
WO2012112749A2 (en) 2011-02-18 2012-08-23 Sequent Medical, Inc. Blood flow disruption devices and methods for the treatment of vascular defects
DE102011011869A1 (en) 2011-02-22 2012-08-23 Phenox Gmbh implant
DE102011012501A1 (en) 2011-02-25 2012-08-30 Phenox Gmbh Implant with fiber fleece
WO2012118957A2 (en) 2011-03-02 2012-09-07 Eskridge Joe Michael Endovascular closure system
JP6078480B2 (en) 2011-03-09 2017-02-08 オカルジェル Implantable swellable bioabsorbable polymer
WO2012134990A1 (en) 2011-03-25 2012-10-04 Tyco Healthcare Group Lp Vascular remodeling device
US10028745B2 (en) 2011-03-30 2018-07-24 Noha, Llc Advanced endovascular clip and method of using same
US20130190805A1 (en) 2011-03-31 2013-07-25 DePuy Synthes Products, LLC Method of fabricating modifiable occlusion device
US20120253377A1 (en) 2011-03-31 2012-10-04 Codman & Shurtleff, Inc. Modifiable occlusion device
US20130204288A1 (en) 2011-03-31 2013-08-08 DePuy Synthes Products, LLC Modifiable occlusion device
US9456823B2 (en) 2011-04-18 2016-10-04 Terumo Corporation Embolic devices
US20120271399A1 (en) 2011-04-19 2012-10-25 Medtronic Vascular, Inc. High Metal to Vessel Ratio Landing Zone Stent-Graft and Method
EP2517671B1 (en) 2011-04-28 2016-05-11 Cook Medical Technologies LLC Apparatus for facilitating deployment of an endoluminal prosthesis
US20120283768A1 (en) 2011-05-05 2012-11-08 Sequent Medical Inc. Method and apparatus for the treatment of large and giant vascular defects
EP2707078B1 (en) 2011-05-11 2017-07-05 Microvention, Inc. Occlusion device for body cavities.
WO2012158883A1 (en) 2011-05-19 2012-11-22 Tyco Healthcare Group Lp Vascular remodeling device
WO2012158881A1 (en) 2011-05-19 2012-11-22 Tyco Healthcare Group Lp Vascular remodeling device
US9138232B2 (en) 2011-05-24 2015-09-22 Aneuclose Llc Aneurysm occlusion by rotational dispensation of mass
KR101480514B1 (en) 2011-05-26 2015-01-09 재단법인 아산사회복지재단 Stent for cerebral aneurysm coil embolization
KR102019025B1 (en) 2011-06-03 2019-09-06 펄사 배스큘라, 아이엔씨. Systems and methods for enclosing an anatomical opening, including shock absorbing aneurysm devices
US9504588B2 (en) 2011-06-05 2016-11-29 The Research Foundation For The State University Of New York System and method for simulating deployment configuration of an expandable device
US20120316632A1 (en) 2011-06-13 2012-12-13 Bulang Gao Retrievable covered stent for bifurcation aneurysms
US9830427B2 (en) 2011-06-20 2017-11-28 Siemens Healthcare Gmbh Method for intracranial aneurysm analysis and endovascular intervention planning
US20120330341A1 (en) 2011-06-22 2012-12-27 Becking Frank P Folded-Flat Aneurysm Embolization Devices
AU2012203620B9 (en) 2011-06-24 2014-10-02 Cook Medical Technologies Llc Helical Stent
US8577693B2 (en) 2011-07-13 2013-11-05 The Invention Science Fund I, Llc Specialty stents with flow control features or the like
JP5665803B2 (en) 2011-07-15 2015-02-04 クック メディカル テクノロジーズ エルエルシーCook Medical Technologies Llc Method for electrospinning a graft layer
US8728094B2 (en) 2011-07-19 2014-05-20 Abbott Cardiovascular Systems Inc. Percutaneous aneurysm inversion and ligation
US9198668B2 (en) 2011-08-04 2015-12-01 Cook Medical Technologies Llc Cerebral aneurysm closure device
AU2012295244B2 (en) 2011-08-12 2015-09-03 W. L. Gore & Associates, Inc. Devices and methods for approximating the cross-sectional profile of vasculature having branches
US20130053872A1 (en) 2011-08-23 2013-02-28 Cook Medical Technologies Llc Device and method for preventing blood flow into an aneurysm
US11185403B2 (en) 2011-08-31 2021-11-30 Cook Medical Technologies Llc Endoluminal prosthesis assembly
EP2755574A1 (en) 2011-09-13 2014-07-23 Stryker Corporation Vaso-occlusive device
WO2013049448A1 (en) 2011-09-29 2013-04-04 Covidien Lp Vascular remodeling device
WO2013049837A1 (en) 2011-09-30 2013-04-04 Medicalcue, Inc. Umbilical probe measurement systems
US20130089576A1 (en) 2011-10-04 2013-04-11 The Texas A&M University System Implantable embolic scaffolds that promote healing
ES2809210T3 (en) 2011-10-05 2021-03-03 Pulsar Vascular Inc Systems and devices for wrapping an anatomical opening
WO2013055703A1 (en) 2011-10-07 2013-04-18 Cornell University Method and apparatus for restricting flow through an opening in a body lumen while maintaining normal flow
US9144486B2 (en) 2011-10-14 2015-09-29 Trivascular, Inc. Fenestrated inflatable graft
US8936784B2 (en) 2011-10-17 2015-01-20 Poly-Med, Inc. Absorbable in situ gel-forming system, method of making and use thereof
US20130289690A1 (en) 2011-11-01 2013-10-31 Hira V. Thapliyal Personalized prosthesis and methods of use
US8771341B2 (en) 2011-11-04 2014-07-08 Reverse Medical Corporation Protuberant aneurysm bridging device and method of use
US9072620B2 (en) 2011-11-04 2015-07-07 Covidien Lp Protuberant aneurysm bridging device deployment method
CN103930154B (en) 2011-11-09 2016-03-23 斯瑞克公司 There is the medical treatment device of bicomponent fibre sleeve pipe
US20130123901A1 (en) 2011-11-14 2013-05-16 Robert A. Connor Stent with in situ determination of wall areas with differences in porosity
EP2782521B1 (en) 2011-11-23 2017-03-08 Microvention, Inc. Embolic device with shaped wire
KR101315443B1 (en) 2011-12-02 2013-10-07 강호창 Micro-coil assembly
US8894701B2 (en) 2011-12-23 2014-11-25 Cook Medical Technologies Llc Hybrid balloon-expandable/self-expanding prosthesis for deployment in a body vessel and method of making
JP2013153810A (en) 2012-01-27 2013-08-15 Terumo Corp Knob treatment device and knob treatment method
JP2013154089A (en) 2012-01-31 2013-08-15 Terumo Corp Aneurysm treatment device and aneurysm treatment method
US20130204351A1 (en) 2012-02-02 2013-08-08 Inceptus Medical LLC Aneurysm Graft Devices And Methods
US9113890B2 (en) 2012-02-06 2015-08-25 Aga Medical Corporation Devices and methods for occluding vascular abnormalities
US9107770B2 (en) 2012-02-14 2015-08-18 W. L. Gore & Associates, Inc. Endoprosthesis with varying compressibility and methods of use
US20130226278A1 (en) 2012-02-23 2013-08-29 Tyco Healthcare Group Lp Methods and apparatus for luminal stenting
US9072624B2 (en) 2012-02-23 2015-07-07 Covidien Lp Luminal stenting
WO2013130937A1 (en) 2012-03-01 2013-09-06 Tufts University Endovascular silk-protein based embolization of blood vessels
US20130245369A1 (en) 2012-03-15 2013-09-19 Sorin Crm Sas Left atrial appendage occlusion systems
EP2825129B2 (en) 2012-03-16 2020-02-19 Terumo Corporation Stent and stent delivery device
US9687245B2 (en) 2012-03-23 2017-06-27 Covidien Lp Occlusive devices and methods of use
US9005270B2 (en) 2012-03-27 2015-04-14 Medtronic Vascular, Inc. High metal to vessel ratio stent and method
US8911490B2 (en) 2012-03-27 2014-12-16 Medtronic Vascular, Inc. Integrated mesh high metal to vessel ratio stent and method
WO2013158781A1 (en) 2012-04-18 2013-10-24 Microvention, Inc. Embolic devices
US8968384B2 (en) 2012-04-27 2015-03-03 Medtronic Vascular, Inc. Circumferentially constraining sutures for a stent-graft
JP6411331B2 (en) 2012-05-10 2018-10-24 パルサー バスキュラー インコーポレイテッド Aneurysm device with coil
US20130310687A1 (en) 2012-05-21 2013-11-21 Terumo Clinical Supply Co., Ltd. Blood vessel embolization method using balloon catheter and balloon catheter for blood vessel embolization method
US20130338688A1 (en) 2012-06-18 2013-12-19 Tausif ur Rehman Sensory vascular clip
US20140018902A1 (en) 2012-07-12 2014-01-16 Makor Issues And Rights Ltd. Tailor-made stent graft and procedure for minimally invasive aneurysm repair with novel tailor-made balloon, novel guidewire, and novel capsulated bioglue
US9155647B2 (en) 2012-07-18 2015-10-13 Covidien Lp Methods and apparatus for luminal stenting
US20140025151A1 (en) 2012-07-20 2014-01-23 Bulang Gao Retrievable stent for intracranial aneurysms
US10159489B2 (en) 2012-07-30 2018-12-25 Cook Medical Technologies Llc Systems and methods for delivering multiple embolization coils
US9277905B2 (en) 2012-08-02 2016-03-08 W. L. Gore & Associates, Inc. Space-filling device
EP2900306B1 (en) 2012-09-27 2016-07-06 Stryker Corporation Method of forming a variably reinforced elongate medical device
US9114001B2 (en) 2012-10-30 2015-08-25 Covidien Lp Systems for attaining a predetermined porosity of a vascular device
US9452070B2 (en) 2012-10-31 2016-09-27 Covidien Lp Methods and systems for increasing a density of a region of a vascular device
US9186267B2 (en) 2012-10-31 2015-11-17 Covidien Lp Wing bifurcation reconstruction device
US20140128901A1 (en) 2012-11-05 2014-05-08 Kevin Kang Implant for aneurysm treatment
US9943427B2 (en) 2012-11-06 2018-04-17 Covidien Lp Shaped occluding devices and methods of using the same
US20140130965A1 (en) 2012-11-12 2014-05-15 Medtronic Vascular, Inc. Method of Manufacturing a Stent-Graft Prosthesis With Two Layers of Expanded Polytetrafluoroethylene
KR102309795B1 (en) 2012-11-13 2021-10-08 코비디엔 엘피 Occlusive devices
US8597323B1 (en) 2012-11-16 2013-12-03 Sequent Medical, Inc. Delivery and detachment systems and methods for vascular implants
US20140180377A1 (en) 2012-12-20 2014-06-26 Penumbra, Inc. Aneurysm occlusion system and method
US20140180387A1 (en) 2012-12-21 2014-06-26 Stryker Nv Operations Limited Stent delivery system
US10219924B2 (en) 2012-12-26 2019-03-05 Stryker Corporation Multilayer stent
WO2014110231A2 (en) 2013-01-10 2014-07-17 Trivascular, Inc. Sac liner for aneurysm repair
US10342546B2 (en) 2013-01-14 2019-07-09 Microvention, Inc. Occlusive device
US9295571B2 (en) 2013-01-17 2016-03-29 Covidien Lp Methods and apparatus for luminal stenting
US20140214071A1 (en) 2013-01-28 2014-07-31 Neurodynamics, Llc. Embolic coil delivery system and method of using same
US9157174B2 (en) 2013-02-05 2015-10-13 Covidien Lp Vascular device for aneurysm treatment and providing blood flow into a perforator vessel
US9463105B2 (en) 2013-03-14 2016-10-11 Covidien Lp Methods and apparatus for luminal stenting
US9498360B2 (en) 2013-03-15 2016-11-22 Stryker Corporation Stent and method of use
US8690907B1 (en) 2013-03-15 2014-04-08 Insera Therapeutics, Inc. Vascular treatment methods
US8715314B1 (en) 2013-03-15 2014-05-06 Insera Therapeutics, Inc. Vascular treatment measurement methods
US9566071B2 (en) 2013-04-11 2017-02-14 Blockade Medical, LLC Systems and devices for cerebral aneurysm repair

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20160220396A1 (en) * 2011-09-09 2016-08-04 Isis Innovation Limited Stent and method of inserting a stent into a delivery catheter
US10383749B2 (en) * 2011-09-09 2019-08-20 Oxford University Innovation Limited Stent and method of inserting a stent into a delivery catheter
US20150216684A1 (en) * 2012-08-17 2015-08-06 The Regents Of The University Of California Dual rotational stent apparatus and method for endovascular treatment of aneurysms
US9763812B2 (en) * 2012-08-17 2017-09-19 The Regents Of The University Of California Dual rotational stent apparatus and method for endovascular treatment of aneurysms
EP4138741A4 (en) * 2020-04-20 2023-12-27 Exovitra LLC Methods and systems for treatment of aneurysms

Also Published As

Publication number Publication date
US9358140B1 (en) 2016-06-07

Similar Documents

Publication Publication Date Title
US20100131002A1 (en) Stent with a net layer to embolize and aneurysm
US9358140B1 (en) Stent with outer member to embolize an aneurysm
US8974487B2 (en) Aneurysm occlusion device
CN106456182B (en) Vascular occlusion device
JP4472525B2 (en) Embolizer for vascular lesions
US10028747B2 (en) Coils with a series of proximally-and-distally-connected loops for occluding a cerebral aneurysm
US8425548B2 (en) Occluding member expansion and then stent expansion for aneurysm treatment
JP4324103B2 (en) Stretch resistant treatment device
US10028745B2 (en) Advanced endovascular clip and method of using same
US6511468B1 (en) Device and method for controlling injection of liquid embolic composition
US20080045995A1 (en) Aneurysm buttress arrangement
US20160206321A1 (en) Aneurysm Occlusion Device with Sequence of Shape-Changing Embolic Members
US20160120551A1 (en) Devices and Methods for Occluding a Cerebral Aneurysm
US20040172056A1 (en) Bifurcated aneurysm buttress arrangement
US20190365472A1 (en) Using 3D Imaging and 3D Printing to Occlude a Cerebral Aneurysm
JP2001286478A (en) Aneurysm embolization device inserted in blood vessel
US11471163B2 (en) Intrasaccular aneurysm occlusion device with net or mesh expanded by string-of-pearls embolies
CN114554979A (en) Mesh occluder for improving herniation
US20150238195A1 (en) Methods and systems for performing intralumenal procedures
US20210307760A1 (en) Intrasacular Aneurysm Occlusion Device with a Flexible Net or Mesh and Polymer Longitudinal Embolic Members
US20130046326A1 (en) Methods and systems for performing intralumenal procedures

Legal Events

Date Code Title Description
STCF Information on status: patent grant

Free format text: PATENTED CASE

AS Assignment

Owner name: ANEUCLOSE LLC, MINNESOTA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:JANJUA, MUHAMMAD TARIQ;REEL/FRAME:042258/0642

Effective date: 20170405

Owner name: ANEUCLOSE LLC, MINNESOTA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:CONNOR, ROBERT A.;REEL/FRAME:042258/0581

Effective date: 20170405

FEPP Fee payment procedure

Free format text: MAINTENANCE FEE REMINDER MAILED (ORIGINAL EVENT CODE: REM.); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY

LAPS Lapse for failure to pay maintenance fees

Free format text: PATENT EXPIRED FOR FAILURE TO PAY MAINTENANCE FEES (ORIGINAL EVENT CODE: EXP.); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY

STCH Information on status: patent discontinuation

Free format text: PATENT EXPIRED DUE TO NONPAYMENT OF MAINTENANCE FEES UNDER 37 CFR 1.362